Back to Journals » Therapeutics and Clinical Risk Management

Therapeutics and Clinical Risk Management


Journal Articles:

- 1,409 records -

ECMO as an effective rescue therapeutic for fulminant myocarditis complicated with refractory cardiac arrest

Li YT, Yang LF, Chen ZG, Pan L, Duan MQ, Hu Y, Zhou CB, Guo YX

Therapeutics and Clinical Risk Management 2017, 13:1507-1511

Published Date: 14 November 2017

Reversible preoperative renal dysfunction does not add to the risk of postoperative acute kidney injury after cardiac valve surgery

Xu JR, Zhuang YM, Liu L, Shen B, Wang YM, Luo Z, Teng J, Wang CS, Ding XQ

Therapeutics and Clinical Risk Management 2017, 13:1499-1505

Published Date: 10 November 2017

Omentum flap as a salvage procedure in deep sternal wound infection

Rudman F, Barić D, Unić D

Therapeutics and Clinical Risk Management 2017, 13:1495-1497

Published Date: 9 November 2017

Near-fatal asthma responsive to mepolizumab after failure of omalizumab and bronchial thermoplasty

Menzella F, Galeone C, Lusuardi M, Simonazzi A, Castagnetti C, Ruggiero P, Facciolongo N

Therapeutics and Clinical Risk Management 2017, 13:1489-1493

Published Date: 8 November 2017

Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review

Sessa M, Rossi C, Mascolo A, Scavone C, di Mauro G, Grassi R, Sportiello L, Cappabianca S, Rafaniello C

Therapeutics and Clinical Risk Management 2017, 13:1463-1478

Published Date: 24 October 2017

The association of serum vitamin D concentration and ventricular dysfunction among patients with acute coronary syndrome

Khademvatani K, Mohammadzad MS, Yekta Z, Hadizadeh O

Therapeutics and Clinical Risk Management 2017, 13:1455-1461

Published Date: 20 October 2017

Isolated descemetorhexis for anterior synechiolysis prior to endothelial keratoplasty – case report and technique

Droutsas K, Andreanos K, Lazaridis A, Georgalas I, Kymionis G, Papaconstantinou D

Therapeutics and Clinical Risk Management 2017, 13:1443-1447

Published Date: 19 October 2017

Comparative analysis of the long-term effect of two families of high-flux polysulfone dialysers on platelet count: a retrospective cross-sectional study

Del Giorno R, Berwert L, Pianca S, Bianchi G, Giannini O, Gabutti L

Therapeutics and Clinical Risk Management 2017, 13:1415-1422

Published Date: 16 October 2017

Spontaneous peritonitis in critically ill cirrhotic patients: a diagnostic algorithm for clinicians and future perspectives

Fiore M, Maraolo AE, Leone S, Gentile I, Cuomo A, Schiavone V, Bimonte S, Pace MC, Cascella M

Therapeutics and Clinical Risk Management 2017, 13:1409-1414

Published Date: 16 October 2017

Chronic digitalis therapy in patients before heart transplantation is an independent risk factor for increased posttransplant mortality

Rivinius R, Helmschrott M, Ruhparwar A, Rahm AK, Darche FF, Thomas D, Bruckner T, Ehlermann P, Katus HA, Doesch AO

Therapeutics and Clinical Risk Management 2017, 13:1399-1407

Published Date: 13 October 2017

Immunosuppressants and new onset gallstone disease in patients having undergone renal transplantation

Liu FC, Ting PC, Lin JR, Yu HP

Therapeutics and Clinical Risk Management 2017, 13:1391-1398

Published Date: 13 October 2017

Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring

Chang Y, Tolani B, Nie XH, Zhi XY, Hu M, He B

Therapeutics and Clinical Risk Management 2017, 13:1363-1374

Published Date: 11 October 2017

Fat embolism after fractures in Duchenne muscular dystrophy: an underdiagnosed complication? A systematic review

Feder D, Koch ME, Palmieri B, Fonseca FLA, Carvalho AAS

Therapeutics and Clinical Risk Management 2017, 13:1357-1361

Published Date: 10 October 2017

Effects of sevoflurane versus propofol on cerebrovascular reactivity to carbon dioxide during laparoscopic surgery

Wang C, Ni C, Li G, Li Y, Tao L, Li N, Wang J, Guo X

Therapeutics and Clinical Risk Management 2017, 13:1349-1355

Published Date: 10 October 2017

Decreased frequency of adenoidectomy by a 12-week nasal budesonide treatment

Hong H, Chen F, Zheng X, Liao W, Liao Z, Cao Y, He H, Zhu Z, Fan Y

Therapeutics and Clinical Risk Management 2017, 13:1309-1316

Published Date: 3 October 2017

Perinatal and follow-up outcome study of fetal anomalies with multidisciplinary consultation

Li G, Yang N, Xie M, Xu YJ, Han N, Chen Q, Li H, Wu Y, Cheng CH, Wang Y, Zhou M, Xia B, Guo S, Cui S

Therapeutics and Clinical Risk Management 2017, 13:1303-1307

Published Date: 4 October 2017

Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?

Kahraman R, Calhan T, Sahin A, Ozdil K, Caliskan Z, Bireller ES, Cakmakoglu B

Therapeutics and Clinical Risk Management 2017, 13:1295-1301

Published Date: 30 September 2017

Robot-assisted versus conventional laparoscopic operation in anus-preserving rectal cancer: a meta-analysis

Cui Y, Li C, Xu Z, Wang Y, Sun Y, Xu H, Li Z, Sun Y

Therapeutics and Clinical Risk Management 2017, 13:1247-1257

Published Date: 22 September 2017

Surgical site infections following instrumented stabilization of the spine

Dapunt U, Bürkle C, Günther F, Pepke W, Hemmer S, Akbar M

Therapeutics and Clinical Risk Management 2017, 13:1239-1245

Published Date: 20 September 2017

Ten-year outcome of intraoperative treatment of atrial fibrillation using radiofrequency ablation

Boulad N, Shammas NW, Early G, Roberts S, Shammas GA, Hu YL, Park H, Jerin M

Therapeutics and Clinical Risk Management 2017, 13:1233-1237

Published Date: 19 September 2017

Role of heart-rate variability in preoperative assessment of physiological reserves in patients undergoing major abdominal surgery

Reimer P, Máca J, Szturz P, Jor O, Kula R, Ševčík P, Burda M, Adamus M

Therapeutics and Clinical Risk Management 2017, 13:1223-1231

Published Date: 19 September 2017

Bronchial thermoplasty and the role of airway smooth muscle: are we on the right direction?

Menzella F, Lusuardi M, Galeone C, Facciolongo N

Therapeutics and Clinical Risk Management 2017, 13:1213-1221

Published Date: 19 September 2017

Increased risk of pernicious anemia following scabies: a nationwide population-based matched-cohort study

Liu JM, Hsu RJ, Chang FW, Chiu FH, Yeh CL, Huang CF, Chang ST, Lee HC, Chi H, Lin CY

Therapeutics and Clinical Risk Management 2017, 13:1205-1211

Published Date: 13 September 2017

Relevance of the Weber effect in contemporary pharmacovigilance of oncology drugs

Arora A, Jalali RK, Vohora D

Therapeutics and Clinical Risk Management 2017, 13:1195-1203

Published Date: 11 September 2017

Treatment of pretibial myxedema with intralesional immunomodulating therapy

Ren Z, He M, Deng F, Chen Y, Chai L, Chen B, Deng W

Therapeutics and Clinical Risk Management 2017, 13:1189-1194

Published Date: 8 September 2017

Pharmacovigilance and adverse drug reaction reporting: a perspective of community pharmacists and pharmacy technicians in Sana’a, Yemen

Al-Worafi YM, Kassab YW, Alseragi WM, Almutairi MS, Ahmed A, Ming LC, Alkhoshaiban AS, Hadi MA

Therapeutics and Clinical Risk Management 2017, 13:1175-1181

Published Date: 7 September 2017

The challenge of perioperative pain management in opioid-tolerant patients

Coluzzi F, Bifulco F, Cuomo A, Dauri M, Leonardi C, Melotti RM, Natoli S, Romualdi P, Savoia G, Corcione A

Therapeutics and Clinical Risk Management 2017, 13:1163-1173

Published Date: 5 September 2017

Dupilumab in the management of moderate-to-severe asthma: the data so far

Barranco P, Phillips-Angles E, Dominguez-Ortega J, Quirce S

Therapeutics and Clinical Risk Management 2017, 13:1139-1149

Published Date: 1 September 2017

Operative and nonoperative management for renal trauma: comparison of outcomes. A systematic review and meta-analysis

Mingoli A, La Torre M, Migliori E, Cirillo B, Zambon M, Sapienza P, Brachini G

Therapeutics and Clinical Risk Management 2017, 13:1127-1138

Published Date: 31 August 2017

Predicting and managing sepsis in burn patients: current perspectives

Nunez Lopez O, Cambiaso-Daniel J, Branski LK, Norbury WB, Herndon DN

Therapeutics and Clinical Risk Management 2017, 13:1107-1117

Published Date: 29 August 2017

Curcumin inhibits apoptosis by modulating Bax/Bcl-2 expression and alleviates oxidative stress in testes of streptozotocin-induced diabetic rats

Zhao L, Gu Q, Xiang L, Dong X, Li H, Ni J, Wan L, Cai G, Chen G

Therapeutics and Clinical Risk Management 2017, 13:1099-1105

Published Date: 28 August 2017

Frequent respiratory events in postoperative patients aged 60 years and above

Broens SJL, He X, Evley R, Olofsen E, Niesters M, Mahajan RP, Dahan A, van Velzen M

Therapeutics and Clinical Risk Management 2017, 13:1091-1098

Published Date: 26 August 2017

Radiologic findings of thoracic trauma

Akgul Ozmen C, Onat S, Aycicek D

Therapeutics and Clinical Risk Management 2017, 13:1085-1089

Published Date: 26 August 2017

Omentum flap as a salvage procedure in deep sternal wound infection

Spindler N, Etz CD, Misfeld M, Josten C, Mohr FW, Langer S

Therapeutics and Clinical Risk Management 2017, 13:1077-1083

Published Date: 23 August 2017

Hollow viscus injuries: predictors of outcome and role of diagnostic delay

Mingoli A, La Torre M, Brachini G, Costa G, Balducci G, Frezza B, Sgarzini G, Cirillo B

Therapeutics and Clinical Risk Management 2017, 13:1069-1076

Published Date: 23 August 2017

Impact of immunosuppressant therapy on new-onset diabetes in liver transplant recipients

Liu FC, Lin HT, Lin JR, Yu HP

Therapeutics and Clinical Risk Management 2017, 13:1043-1051

Published Date: 18 August 2017

Prevalence and predictors of sleep apnea in patients with stable coronary artery disease: a cross-sectional study

Alonderis A, Varoneckas G, Raskauskiene N, Brozaitiene J

Therapeutics and Clinical Risk Management 2017, 13:1031-1042

Published Date: 18 August 2017

Risk factors and early outcomes of acute renal injury after thoracic aortic endograft repair for type B aortic dissection

Luo S, Ding H, Luo J, Li W, Ning B, Liu Y, Huang W, Xue L, Fan R, Chen J

Therapeutics and Clinical Risk Management 2017, 13:1023-1029

Published Date: 17 August 2017

The value of time-averaged serum high-sensitivity C-reactive protein in prediction of mortality and dropout in peritoneal dialysis patients

Liu SH, Chen CY, Li YJ, Wu HH, Lin CY, Chen YC, Chang MY, Hsu HH, Ku CL, Tian YC

Therapeutics and Clinical Risk Management 2017, 13:1009-1021

Published Date: 16 August 2017

Adverse outcomes after percutaneous dilatational tracheostomy versus surgical tracheostomy in intensive care patients: case series and literature review

Jarosz K, Kubisa B, Andrzejewska A, Mrówczyńska K, Hamerlak Z, Bartkowska-Śniatkowska A

Therapeutics and Clinical Risk Management 2017, 13:975-981

Published Date: 7 August 2017

Neutrophil/lymphocyte ratio and mean platelet volume in central serous chorioretinopathy

Erol MK, Balkarli A, Yucel O, Akar Y, Dogan B, Suren E

Therapeutics and Clinical Risk Management 2017, 13:945-950

Published Date: 28 July 2017

The role of mediastinoscopy in the diagnosis of non-lung cancer diseases

Onat S, Ates G, Avci A, Yildiz T, Birak A, Akgul Ozmen C, Ulku R

Therapeutics and Clinical Risk Management 2017, 13:939-943

Published Date: 27 July 2017

Helicobacter pylori infection and severity of coronary atherosclerosis in patients with chronic coronary artery disease

Jukic A, Bozic D, Kardum D, Becic T, Luksic B, Vrsalovic M, Ljubkovic M, Fabijanic D

Therapeutics and Clinical Risk Management 2017, 13:933-938

Published Date: 27 July 2017

Management of traumatic tympanic membrane perforation: a comparative study

Gao TX, Li XL, Hu J, Ma WJ, Li JJ, Shao N, Wang ZH

Therapeutics and Clinical Risk Management 2017, 13:927-931

Published Date: 24 July 2017

Thyroid cancer in a patient with Lynch syndrome – case report and literature review

Fazekas-Lavu M, Parker A, Spigelman AD, Scott RJ, Epstein RJ, Jensen M, Samaras K

Therapeutics and Clinical Risk Management 2017, 13:915-918

Published Date: 21 July 2017

Collaboration in pharmacovigilance: lamotrigine and fatal severe cutaneous adverse reactions – a review of spontaneous reports

Brickel N, Shaikh H, Kirkham A, Davies G, Chalker M, Yoshida P

Therapeutics and Clinical Risk Management 2017, 13:897-903

Published Date: 20 July 2017

Sex differences of in-hospital outcome and long-term mortality in patients with Takotsubo cardiomyopathy

Weidner KJ, El-Battrawy I, Behnes M, Schramm K, Fastner C, Kuschyk J, Hoffmann U, Ansari U, Borggrefe M, Akin I

Therapeutics and Clinical Risk Management 2017, 13:863-869

Published Date: 12 July 2017

Reconstruction of fingers after electrical injury using lateral tarsal artery flap

Zhang MH, Huang MT, Zhang PH, Liang PF, Ren LC, Zeng JZ, Zhou J, Liu X, Xie TH, Huang X

Therapeutics and Clinical Risk Management 2017, 13:855-861

Published Date: 10 July 2017

Clinical patterns and outcomes of status epilepticus in patients with tuberous sclerosis complex

Shehata HS, AbdelGhaffar HM, Nasreldin M, Elmazny A, Abdelalim A, Sabbah A, Shalaby NM

Therapeutics and Clinical Risk Management 2017, 13:779-785

Published Date: 30 June 2017

Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review

Solmi M, Murru A, Pacchiarotti I, Undurraga J, Veronese N, Fornaro M, Stubbs B, Monaco F, Vieta E, Seeman MV, Correll CU, Carvalho AF

Therapeutics and Clinical Risk Management 2017, 13:757-777

Published Date: 29 June 2017

Onset of chronic myeloid leukemia with complex karyotype in a pregnant patient: case report and revision of literature

Sgherza N, Abruzzese E, Perla G, Minervini MM, Chiello V, Sciannamè N, Cascavilla N

Therapeutics and Clinical Risk Management 2017, 13:751-755

Published Date: 27 June 2017

Four novel ARSA gene mutations with pathogenic impacts on metachromatic leukodystrophy: a bioinformatics approach to predict pathogenic mutations

Dehghan Manshadi M, Kamalidehghan B, Aryani O, Khalili E, Dadgar S, Tondar M, Ahmadipour F, Yong Meng G, Houshmand M

Therapeutics and Clinical Risk Management 2017, 13:725-731

Published Date: 16 June 2017

Blood lead level is a positive predictor of uremic pruritus in patients undergoing hemodialysis

Weng CH, Hsu CW, Hu CC, Yen TH, Chan MJ, Huang WH

Therapeutics and Clinical Risk Management 2017, 13:717-723

Published Date: 12 June 2017

Transnasal endoscopic and combined intra–extranasal approach for the surgical treatment of frontal sinus cerebrospinal fluid rhinorrhea

Yang Q, Li P, Huang J, Wang W, Bian SY, Huang X, Liu X, Zhang G

Therapeutics and Clinical Risk Management 2017, 13:709-715

Published Date: 9 June 2017

Noncontact plating technique in an open fracture

Tuhanioğlu Ü, Oğur HU, Çiçek H, Seyfettinoğlu F, Çiloğlu O, Kapukaya A

Therapeutics and Clinical Risk Management 2017, 13:703-708

Published Date: 8 June 2017

Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide

Cozzolino M, Galassi A, Conte F, Mangano M, Di Lullo L, Bellasi A

Therapeutics and Clinical Risk Management 2017, 13:679-689

Published Date: 1 June 2017

Treatment and outcome of intestinal perforation after liver transplant surgery in adults: a single-center experience

Lin J, Wang J, Yue P, Zhang X, Lang R, Wang Y, Cui C, He Q

Therapeutics and Clinical Risk Management 2017, 13:675-678

Published Date: 31 May 2017

Color M-mode echocardiography-derived propagation velocity of descending aorta decreases with aging

Yaman M, Arslan U, Bayramoğlu A, Bektaş O, Karataş A

Therapeutics and Clinical Risk Management 2017, 13:669-674

Published Date: 24 May 2017

Comparison of the clinical features and outcomes of infective endocarditis between hemodialysis and non-hemodialysis patients

Hsiao CC, Weng CH, Li YJ, Wu HH, Chen YC, Chen YM, Hsu HH, Tian YC

Therapeutics and Clinical Risk Management 2017, 13:663-668

Published Date: 24 May 2017

A retrograde y-stenting of the trachea for treatment of mediastinal fistula in an unusual situation

Hohenforst-Schmidt W, Zarogoulidis P, Steinheimer M, Schneider T, Benhassen N, Rupprecht H, Freitag L

Therapeutics and Clinical Risk Management 2017, 13:655-661

Published Date: 23 May 2017

Effect of treatment with single total-dose intravenous iron versus daily oral iron(III)-hydroxide polymaltose on moderate puerperal iron-deficiency anemia

Iyoke CA, Emegoakor FC, Ezugwu EC, Lawani LO, Ajah LO, Madu JA, Ezegwui HU, Ezugwu FO

Therapeutics and Clinical Risk Management 2017, 13:647-653

Published Date: 17 May 2017

Iatrogenic visual aura: a case report and a brief review of the literature

Buture A, Khalil M, Ahmed F

Therapeutics and Clinical Risk Management 2017, 13:643-646

Published Date: 17 May 2017

Protocol for management after thyroidectomy: a retrospective study based on one-center experience

Luo H, Yang HL, Wei T, Gong YP, Su AP, Ma Y, Zou XH, Lei JY, Zhao WJ, Zhu JQ

Therapeutics and Clinical Risk Management 2017, 13:635-641

Published Date: 15 May 2017

Pulmonary hypertension and vasculopathy in incontinentia pigmenti: a case report

Alshenqiti A, Nashabat M, AlGhoraibi H, Tamimi O, Alfadhel M

Therapeutics and Clinical Risk Management 2017, 13:629-634

Published Date: 9 May 2017

Misoprostol for miscarriage management in a woman with previous five cesarean deliveries: a case report and literature review

AlSaad D, Al-Obaidly S, Abdulrouf P, Thomas B, Ahmed A, AlHail M

Therapeutics and Clinical Risk Management 2017, 13:625-627

Published Date: 9 May 2017

Changing health care culture: a prerequisite to improving patient safety

Azizi S, Siddiqui F, Iqbal I

Therapeutics and Clinical Risk Management 2017, 13:623-624

Published Date: 8 May 2017

Clinical and genetic characteristics in a group of 45 patients with Turner syndrome (monocentric study)

Bucerzan S, Miclea D, Popp R, Alkhzouz C, Lazea C, Pop IV, Grigorescu-Sido P

Therapeutics and Clinical Risk Management 2017, 13:613-622

Published Date: 4 May 2017

Differential cardiovascular profiles of sodium-glucose cotransporter 2 inhibitors: critical evaluation of empagliflozin

Sanon VP, Patel S, Sanon S, Rodriguez R, Pham SV, Chilton R

Therapeutics and Clinical Risk Management 2017, 13:603-611

Published Date: 3 May 2017

Minimally invasive endoscopic resection for the treatment of sinonasal malignancy: the outcomes and risk factors for recurrence

He N, Chen XH, Zhang L, Chen XJ, Huang ZG, Zhong Q, Ma HZ, Feng L, Hou LZ, Fang JG

Therapeutics and Clinical Risk Management 2017, 13:593-602

Published Date: 3 May 2017

Narrowband ultraviolet B light treatment changes plasma concentrations of MMP-3, MMP-9 and TIMP-3 in psoriatic patients

Głażewska EK, Niczyporuk M, Ławicki S, Szmitkowski M, Donejko M, Zajkowska M, Będkowska GE, Przylipiak A

Therapeutics and Clinical Risk Management 2017, 13:575-582

Published Date: 27 April 2017

Positive correlation between environmental PM2.5 and blood lead levels in patients undergoing maintenance hemodialysis

Chen CY, Liu MH, Hsu CW, Weng CH, Yen TH, Huang WH

Therapeutics and Clinical Risk Management 2017, 13:555-564

Published Date: 24 April 2017

The effect of sodium hyaluronate–chondroitin sulfate combined solution on cartilage formation in osteochondral defects of the rabbit knee: an experimental study

Tosun HB, Gürger M, Gümüştaş SA, Uludag A, Üçer Ö, Serbest S, Çelik S

Therapeutics and Clinical Risk Management 2017, 13:523-532

Published Date: 18 April 2017

Patient characteristics associated with false arrhythmia alarms in intensive care

Harris PR, Zègre-Hemsey JK, Schindler D, Bai Y, Pelter MM, Hu X

Therapeutics and Clinical Risk Management 2017, 13:499-513

Published Date: 19 April 2017

Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis

Moayeri A, Mohamadpour M, Mousavi SF, Shirzadpour E, Mohamadpour S, Amraei M

Therapeutics and Clinical Risk Management 2017, 13:455-468

Published Date: 11 April 2017

Genetic factors in pathogenesis of diabetes mellitus after kidney transplantation

Tarnowski M, Słuczanowska-Głabowska S, Pawlik A, Mazurek-Mochol M, Dembowska E

Therapeutics and Clinical Risk Management 2017, 13:439-446

Published Date: 6 April 2017

Role of pirfenidone in the management of pulmonary fibrosis

Meyer KC, Decker CA

Therapeutics and Clinical Risk Management 2017, 13:427-437

Published Date: 3 April 2017

Polymorphisms of VKORC1 and CYP2C9 are associated with warfarin sensitivity in Chinese population

Jia LQ, Wang Z, Men J, Cai H, Wei M

Therapeutics and Clinical Risk Management 2017, 13:421-425

Published Date: 31 March 2017

Drug-related problems in patients with erectile dysfunctions and multiple comorbidities

Huri HZ, Ling CF, Razack AH

Therapeutics and Clinical Risk Management 2017, 13:407-419

Published Date: 31 March 2017

Predictors of common femoral artery access site complications in patients on oral anticoagulants and undergoing a coronary procedure

Shammas NW, Shammas GA, Jones-Miller S, Gumpert MR, Gumpert MJ, Harb C, Chammas MZ, Shammas WJ, Khalafallah RA, Barzgari A, Bou Dargham B, Daher GE, Rachwan RJ, Shammas AN

Therapeutics and Clinical Risk Management 2017, 13:401-406

Published Date: 30 March 2017

Predictive values of D-dimer assay, GRACE scores and TIMI scores for adverse outcome in patients with non-ST-segment elevation myocardial infarction

Satilmisoglu MH, Ozyilmaz SO, Gul M, Ak Yildirim H, Kayapinar O, Gokturk K, Aksu H, Erkanli K, Eksik A

Therapeutics and Clinical Risk Management 2017, 13:393-400

Published Date: 29 March 2017

Urinary cadmium levels predict mortality of patients with acute heart failure

Hsu CW, Weng CH, Lee CC, Lin-Tan DT, Chu PH, Chen KH, Yen TH, Huang WH

Therapeutics and Clinical Risk Management 2017, 13:379-386

Published Date: 27 March 2017

Effects of sharing information on drug administration errors in pediatric wards: a pre–post intervention study

Chua SS, Choo SM, Sulaiman CZ, Omar A, Thong MK

Therapeutics and Clinical Risk Management 2017, 13:345-353

Published Date: 23 March 2017

Second-line afatinib administration in an elderly patient with squamous cell carcinoma

Hohenforst-Schmidt W, Zarogoulidis P, Steinheimer M, Benhassen N, Sardeli C, Stalikas N, Toitou M, Huang H

Therapeutics and Clinical Risk Management 2017, 13:341-343

Published Date: 20 March 2017

Clinical characteristics of zinc phosphide poisoning in Thailand

Trakulsrichai S, Kosanyawat N, Atiksawedparit P, Sriapha C, Tongpoo A, Udomsubpayakul U, Rittilert P, Wananukul W

Therapeutics and Clinical Risk Management 2017, 13:335-340

Published Date: 14 March 2017

An estimate of the cost of administering intravenous biological agents in Spanish day hospitals

Nolla JM, Martín E, Llamas P, Manero J, Rodríguez de la Serna A, Fernández-Miera MF, Rodríguez M, López JM, Ivanova A, Aragón B

Therapeutics and Clinical Risk Management 2017, 13:325-334

Published Date: 14 March 2017

The risk reduction of recurrent periodontal pathogens of local application minocycline HCl 2% gel, used as an adjunct to scaling and root planing for chronic periodontitis treatment

Soeroso Y, Akase T, Sunarto H, Kemal Y, Salim R, Octavia M, Viandita A, Setiawan J, Bachtiar BM

Therapeutics and Clinical Risk Management 2017, 13:307-314

Published Date: 10 March 2017

Clinical role of brexpiprazole in depression and schizophrenia

Parikh NB, Robinson DM, Clayton AH

Therapeutics and Clinical Risk Management 2017, 13:299-306

Published Date: 10 March 2017

The influence of surgical technique on early posttransplant atrial fibrillation — comparison of biatrial, bicaval, and total orthotopic heart transplantation

Rivinius R, Helmschrott M, Ruhparwar A, Erbel C, Gleissner CA, Darche FF, Thomas D, Bruckner T, Katus HA, Doesch AO

Therapeutics and Clinical Risk Management 2017, 13:287-297

Published Date: 8 March 2017

High expression of Aldolase A predicts poor survival in patients with clear-cell renal cell carcinoma

Na N, Li H, Xu CF, Miao B, Hong LQ, Huang ZY, Jiang Q

Therapeutics and Clinical Risk Management 2017, 13:279-285

Published Date: 27 February 2017

Helicobacter pylori infection is not associated with failure to thrive: a case–control study

Chiu NC, Lin CY, Chi H, Yeung CY, Ting WH, Chan WT, Jiang CB, Li ST, Lin CH, Lee HC

Therapeutics and Clinical Risk Management 2017, 13:273-278

Published Date: 23 February 2017

Psychological factors as risk factors for poor hip function after total hip arthroplasty

Benditz A, Jansen P, Schaible J, Roll C, Grifka J, Götz J

Therapeutics and Clinical Risk Management 2017, 13:237-244

Published Date: 21 February 2017

Update on targeted therapies for advanced non-small cell lung cancer: nivolumab in context

Le AD, Alzghari SK, Jean GW, La-Beck NM

Therapeutics and Clinical Risk Management 2017, 13:223-236

Published Date: 21 February 2017

Statin therapy reduces the likelihood of suboptimal blood pressure control among Ugandan adult diabetic patients

Lumu W, Kampiire L, Akabwai GP, Kiggundu DS, Kibirige D

Therapeutics and Clinical Risk Management 2017, 13:215-221

Published Date: 20 February 2017

Ruxolitinib in myelofibrosis: to be or not to be an immune disruptor

Manduzio P

Therapeutics and Clinical Risk Management 2017, 13:169-177

Published Date: 13 February 2017

Short-term bisphosphonate treatment reduces serum 25(OH) vitamin D3 and alters values of parathyroid hormone, pentosidine, and bone metabolic markers

Kamimura M, Uchiyama S, Nakamura Y, Ikegami S, Mukaiyama K, Kato H

Therapeutics and Clinical Risk Management 2017, 13:161-168

Published Date: 13 February 2017

Emergency thoracic ultrasound and clinical risk management

Interrigi MC, Trovato FM, Catalano D, Trovato GM

Therapeutics and Clinical Risk Management 2017, 13:151-160

Published Date: 9 February 2017

Effect of orlistat on periostin, adiponectin, inflammatory markers and ultrasound grades of fatty liver in obese NAFLD patients

Ali Khan R, Kapur P, Jain A, Farah F, Bhandari U

Therapeutics and Clinical Risk Management 2017, 13:139-149

Published Date: 20 February 2017

Prevalence of metabolic syndrome in adolescents living in Mthatha, South Africa

Sekokotla MA, Goswami N, Sewani-Rusike CR, Iputo JE, Nkeh-Chungag BN

Therapeutics and Clinical Risk Management 2017, 13:131-137

Published Date: 7 February 2017

Antitumor effects of oncolytic herpes simplex virus type 2 against colorectal cancer in vitro and in vivo

Yin L, Zhao C, Han J, Li Z, Zhen Y, Xiao R, Xu Z, Sun Y

Therapeutics and Clinical Risk Management 2017, 13:117-130

Published Date: 7 February 2017

Fibrin sheaths in central venous port catheters: treatment with low-dose, single injection of urokinase on an outpatient basis

Chang DH, Mammadov K, Hickethier T, Borggrefe J, Hellmich M, Maintz D, Kabbasch C

Therapeutics and Clinical Risk Management 2017, 13:111-115

Published Date: 24 January 2017

Effects of bariatric surgery on urinary incontinence

Bulbuller N, Habibi M, Yuksel M, Ozener O, Oruc MT, Oner OZ, Kazak MA

Therapeutics and Clinical Risk Management 2017, 13:95-100

Published Date: 19 January 2017

Rapid virological response of telaprevir and boceprevir in a Brazilian cohort of HCV genotype 1 patients: a multicenter longitudinal study

Borba HHL, Wiens A, Steimbach LM, Tonin FS, Pedroso MLA, Ivantes CAP, Fernandez-Llimos F, Pontarolo R

Therapeutics and Clinical Risk Management 2017, 13:59-64

Published Date: 10 January 2017

The association of nephrolithiasis with metabolic syndrome and its components: a cross-sectional analysis

Liu YT, Yang PY, Yang YW, Sun HY, Lin IC

Therapeutics and Clinical Risk Management 2017, 13:41-48

Published Date: 6 January 2017

A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab

Affronti ML, Woodring S, Peters KB, Herndon II JE, McSherry F, Healy PN, Desjardins A, Vredenburgh JJ, Friedman HS

Therapeutics and Clinical Risk Management 2017, 13:33-40

Published Date: 23 December 2016

Identification of a new mutation in an Iranian family with hereditary multiple osteochondromas

Akbaroghli S, Balali M, Kamalidehghan B, Saber S, Aryani O, Yong Meng G, Houshmand M

Therapeutics and Clinical Risk Management 2017, 13:15-19

Published Date: 20 December 2016

Diagnostic accuracy of nodular gastritis for H. pylori infection

Romero-Flores JL, Fernandez-Rivero JA, Marroquín-Fabian E, Téllez-Avila FI, Sánchez-Jiménez BA, Juárez-Hernández E, Uribe M, Chávez-Tapia NC

Therapeutics and Clinical Risk Management 2017, 13:9-14

Published Date: 16 December 2016

Urinary tract infections in Romanian patients with diabetes: prevalence, etiology, and risk factors

Chiţă T, Timar B, Muntean D, Bădițoiu L, Horhat F, Hogea E, Moldovan R, Timar R, Licker M

Therapeutics and Clinical Risk Management 2017, 13:1-7

Published Date: 16 December 2016

Impact of preoperative chronic renal failure on liver transplantation: a population-based cohort study

Chung PC, Chen HP, Lin JR, Liu FC, Yu HP

Therapeutics and Clinical Risk Management 2016, 12:1855-1860

Published Date: 14 December 2016

Kinetics of circulating endothelial progenitor cells in patients undergoing carotid artery surgery

Kalender G, Kornberger A, Lisy M, Beiras-Fernandez A, Stock UA

Therapeutics and Clinical Risk Management 2016, 12:1841-1847

Published Date: 14 December 2016

High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis

Ishikawa K, Nagai T, Sakamoto K, Ohara K, Eguro T, Ito H, Toyoshima Y, Kokaze A, Toyone T, Inagaki K

Therapeutics and Clinical Risk Management 2016, 12:1831-1840

Published Date: 5 December 2016

Complete blood cell count components and coronary slow-flow phenomenon

Arjmand N, Dehghani MR

Therapeutics and Clinical Risk Management 2016, 12:1827-1829

Published Date: 2 December 2016

Preoperative risk factors in total thyroidectomy of substernal goiter

Bove A, Di Renzo RM, D'Urbano G, Bellobono M, D'Addetta V, Lapergola A, Bongarzoni G

Therapeutics and Clinical Risk Management 2016, 12:1805-1809

Published Date: 28 November 2016

Role of anuria in the relationship between indoxyl sulfate and anemia in peritoneal dialysis patients

Huang JY, Hsu CW, Yang CW, Hung CC, Huang WH

Therapeutics and Clinical Risk Management 2016, 12:1797-1803

Published Date: 28 November 2016

Health behaviors of patients diagnosed with type 2 diabetes mellitus and their influence on the patients’ satisfaction with life

Rosiek A, Kornatowski T, Frąckowiak-Maciejewska N, Rosiek-Kryszewska A, Wyżgowski P, Leksowski K

Therapeutics and Clinical Risk Management 2016, 12:1783-1792

Published Date: 25 November 2016

Balanced discussion of second-generation antihistamines' data

Boev R, Bentz JWG

Therapeutics and Clinical Risk Management 2016, 12:1777-1781

Published Date: 24 November 2016

Thyroid dysfunction among type 2 diabetic female Egyptian subjects

Elebrashy IN, El Meligi A, Rashed L, Salam RF, Youseef E, Fathy SA

Therapeutics and Clinical Risk Management 2016, 12:1757-1762

Published Date: 21 November 2016

Pharmaceutical interventions in the management of tuberculosis in a pneumophtisiology department, Ivory Coast

Abrogoua DP, Kamenan BAT, Ahui BJM, Doffou E

Therapeutics and Clinical Risk Management 2016, 12:1749-1756

Published Date: 22 November 2016

Intestinal permeability in a patient with liver cirrhosis

Aguirre Valadez JM, Rivera-Espinosa L, Méndez-Guerrero O, Chávez-Pacheco JL, García Juárez I, Torre A

Therapeutics and Clinical Risk Management 2016, 12:1729-1748

Published Date: 18 November 2016

Protective effect of tartary buckwheat on renal function in type 2 diabetics: a randomized controlled trial

Qiu J, Li ZG, Qin YC, Yue YF, Liu YP

Therapeutics and Clinical Risk Management 2016, 12:1721-1727

Published Date: 18 November 2016

The effect of body mass index on perioperative thermoregulation

Özer AB, Yildiz Altun A, Erhan ÖL, Çatak T, Karatepe Ü, Demirel İ, Çağlar Toprak G

Therapeutics and Clinical Risk Management 2016, 12:1717-1720

Published Date: 18 November 2016

Treatment cost of narcolepsy with cataplexy in Central Europe

Maresova P, Novotny M, Klímová B, Kuča K

Therapeutics and Clinical Risk Management 2016, 12:1709-1715

Published Date: 18 November 2016

Predictive value of serum uric acid in hospitalized adolescents and adults with acute asthma

Abdulnaby NK, Sayed AO, Shalaby NM

Therapeutics and Clinical Risk Management 2016, 12:1701-1708

Published Date: 14 November 2016

Effectiveness of etofenamate for treatment of knee osteoarthritis: a randomized controlled trial

Güner S, Gökalp MA, Gözen A, Ünsal SŞ, Güner Şİ

Therapeutics and Clinical Risk Management 2016, 12:1693-1699

Published Date: 14 November 2016

Inflammation-modulating cytokine profile and lipid interaction in HIV-related risk factors for cardiovascular diseases

Gori E, Mduluza T, Nyagura M, Stray-Pedersen B, Gomo ZA

Therapeutics and Clinical Risk Management 2016, 12:1659-1666

Published Date: 11 November 2016

Antiallergic effect of the atomized extract of rhizome of Curcuma longa, flowers of Cordia lutea and leaves of Annona muricata

Arroyo-Acevedo J, Franco-Quino C, Ruiz-Ramírez E, Chávez-Asmat R, Anampa-Guzmán A, Raéz-González E, Cabanillas-Coral J

Therapeutics and Clinical Risk Management 2016, 12:1643-1647

Published Date: 10 November 2016

Management of extrapulmonary sarcoidosis: challenges and solutions

Al-Kofahi K, Korsten P, Ascoli C, Virupannavar S, Mirsaeidi M, Chang I, Qaqish N, Saketkoo LA, Baughman RP, Sweiss NJ

Therapeutics and Clinical Risk Management 2016, 12:1623-1634

Published Date: 7 November 2016

Shear wave elastography imaging for assessing the chronic pathologic changes in advanced diabetic kidney disease

Hassan K, Loberant N, Abbas N, Fadi H, Shadia H, Khazim K

Therapeutics and Clinical Risk Management 2016, 12:1615-1622

Published Date: 7 November 2016

Patent ductus arteriosus with persistent pulmonary artery hypertension after transcatheter closure

Feng JQ, Kong XQ, Sheng YH, Yang R

Therapeutics and Clinical Risk Management 2016, 12:1609-1613

Published Date: 3 November 2016

Laparoscopic total extraperitoneal repair under spinal anesthesia versus general anesthesia: a randomized prospective study

Donmez T, Erdem VM, Sunamak O, Erdem DA, Avaroglu HI

Therapeutics and Clinical Risk Management 2016, 12:1599-1608

Published Date: 27 October 2016

Costs of inguinal hernia repair associated with using different medical devices in the Czech Republic

Marešová P, Peteja M, Lerch M, Zonca P, Kuca K

Therapeutics and Clinical Risk Management 2016, 12:1593-1597

Published Date: 26 October 2016

Secukinumab for ankylosing spondylitis and psoriatic arthritis

Lubrano E, Perrotta FM

Therapeutics and Clinical Risk Management 2016, 12:1587-1592

Published Date: 21 October 2016

Therapy of psoriasis with narrowband ultraviolet-B light influences plasma concentrations of MMP-2 and TIMP-2 in patients

Głażewska EK, Niczyporuk M, Ławicki S, Szmitkowski M, Zajkowska M, Będkowska GE, Przylipiak A

Therapeutics and Clinical Risk Management 2016, 12:1579-1585

Published Date: 21 October 2016

The potential role for use of mitochondrial DNA copy number as predictive biomarker in presbycusis

Falah M, Houshmand M, Najafi M, Balali M, Mahmoudian S, Asghari A, Emamdjomeh H, Farhadi M

Therapeutics and Clinical Risk Management 2016, 12:1573-1578

Published Date: 19 October 2016

High-frequency oscillatory ventilation is an effective treatment for severe pediatric acute respiratory distress syndrome with refractory hypoxemia

Guo YX, Wang ZN, Li YT, Pan L, Yang LF, Hu Y, Sun YY, Cai LM, Chen ZG

Therapeutics and Clinical Risk Management 2016, 12:1563-1571

Published Date: 19 October 2016

The use of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmatics

Benfante A, Basile M, Battaglia S, Spatafora M, Scichilone N

Therapeutics and Clinical Risk Management 2016, 12:1553-1562

Published Date: 14 October 2016

Comparison of classical diagnostic criteria and Chinese revised diagnostic criteria for fever of unknown origin in Chinese patients

Li JJ, Huang WX, Shi ZY, Sun Q, Xin XJ, Zhao JQ, Yin Z

Therapeutics and Clinical Risk Management 2016, 12:1545-1551

Published Date: 12 October 2016

Impact of statins on risk of new onset diabetes mellitus: a population-based cohort study using the Korean National Health Insurance claims database

Lee J, Noh Y, Shin S, Lim H, Park RW, Bae SK, Oh E, Kim GJ, Kim JH, Lee S

Therapeutics and Clinical Risk Management 2016, 12:1533-1543

Published Date: 11 October 2016

Association of medications for lifestyle-related diseases with reflux esophagitis

Asaoka D, Nagahara A, Hojo M, Matsumoto K, Ueyama H, Matsumoto K, Izumi K, Takeda T, Komori H, Akazawa Y, Shimada Y, Osada T, Watanabe S

Therapeutics and Clinical Risk Management 2016, 12:1507-1515

Published Date: 4 October 2016

Cataract induction by administration of nitroglycerin in cardiac patients through imbalance in redox status

El-Gharabawy RM, Ahmed AS, Al-Najjar AH

Therapeutics and Clinical Risk Management 2016, 12:1487-1496

Published Date: 27 September 2016

The effects of magnesium sulfate therapy after severe diffuse axonal injury

Zhao L, Wang W, Zhong J, Li YY, Cheng YZ, Su Z, Zheng W, Guan XD

Therapeutics and Clinical Risk Management 2016, 12:1481-1486

Published Date: 27 September 2016

Is there any superiority among diagnostic methods in organizing pneumonia in terms of clinical features of the patients?

Kavakli K, Ocal N, Dogan D, Cicek AF, Isik H, Gurkok S

Therapeutics and Clinical Risk Management 2016, 12:1473-1479

Published Date: 26 September 2016

Combined treatment in punctate inner choroidopathy

Terelak-Borys B, Zagajewska K, Jankowska-Lech I, Tesla P, Grabska-Liberek I

Therapeutics and Clinical Risk Management 2016, 12:1467-1471

Published Date: 23 September 2016

Efficacy and safety of daptomycin for skin and soft tissue infections: a systematic review with trial sequential analysis

Liu C, Mao Z, Yang MM, Kang HJ, Liu H, Pan L, Hu J, Luo J, Zhou FH

Therapeutics and Clinical Risk Management 2016, 12:1455-1466

Published Date: 22 September 2016

In vitro and in vivo postmarketing surveillance of valsartan, alone or in combination with amlodipine or hydrochlorthiazide, among Palestinian hypertensive patients

Zaid AN, Ghanem M, Shweiki D, Shtewi H, Shaheen R, Al Helaly S, Khayyat Z, Al Ramahi R, Zyoud SH

Therapeutics and Clinical Risk Management 2016, 12:1425-1432

Published Date: 19 September 2016

Association of low serum aluminum level with mortality in hemodialysis patients

Hsu CW, Weng CH, Lee CC, Lin-Tan DT, Chen KH, Yen TH, Huang WH

Therapeutics and Clinical Risk Management 2016, 12:1417-1424

Published Date: 14 September 2016

Clinical prediction rules for failed nonoperative reduction of intussusception

Khorana J, Patumanond J, Ukarapol N, Laohapensang M, Visrutaratna P, Singhavejsakul J

Therapeutics and Clinical Risk Management 2016, 12:1411-1416

Published Date: 13 September 2016

Reporting of adverse events related to dietary supplements to a public health center by medical staff: a survey of clinics and pharmacies

Ide K, Yamada H, Kawasaki Y, Noguchi M, Kitagawa M, Chiba T, Kagawa Y, Umegaki K

Therapeutics and Clinical Risk Management 2016, 12:1403-1410

Published Date: 12 September 2016

Patients’ safety: is there a systemic release of gentamicin by gentamicin-coated tibia nails in clinical use?

Moghaddam A, Graeser V, Westhauser F, Dapunt U, Kamradt T, Woerner SM, Schmidmaier G

Therapeutics and Clinical Risk Management 2016, 12:1387-1393

Published Date: 7 September 2016

Retargeting the management of hypercholesterolemia – focus on evolocumab

Colletti A, Derosa G, Cicero AFG

Therapeutics and Clinical Risk Management 2016, 12:1365-1376

Published Date: 6 September 2016

Clinical analysis of contributors to the delayed gallbladder opacification following the use of water-soluble contrast medium

Ku MC, Kok VC, Lee MY, Hsu SM, Lee PY, Chang CW, Tyan YS, Juan CW

Therapeutics and Clinical Risk Management 2016, 12:1357-1364

Published Date: 6 September 2016

Safety of long-term use of linezolid: results of an open-label study

Vazquez JA, Arnold AC, Swanson RN, Biswas P, Bassetti M

Therapeutics and Clinical Risk Management 2016, 12:1347-1354

Published Date: 1 September 2016

Does surgical treatment within 4 hours after trauma have an influence on neurological remission in patients with acute spinal cord injury?

Biglari B, Child C, Yildirim TM, Swing T, Reitzel T, Moghaddam A

Therapeutics and Clinical Risk Management 2016, 12:1339-1346

Published Date: 31 August 2016

Rituximab use in adult primary glomerulopathy: where is the evidence?

Mallat SG, Itani HS, Abou-Mrad RM, Abou Arkoub R, Tanios BY

Therapeutics and Clinical Risk Management 2016, 12:1317-1327

Published Date: 29 August 2016

Surgical versus conservative treatment following acute rupture of the Achilles tendon: is there a pedobarographic difference?

Karaaslan F, Mermerkaya MU, Çıraklı A, Karaoğlu S, Duygulu F

Therapeutics and Clinical Risk Management 2016, 12:1311-1315

Published Date: 29 August 2016

Clinical use of blinatumomab for B-cell acute lymphoblastic leukemia in adults

Lee KJ, Chow V, Weissman A, Tulpule S, Aldoss I, Akhtari M

Therapeutics and Clinical Risk Management 2016, 12:1301-1310

Published Date: 25 August 2016

Open-label trial on efficacy of artemether/lumefantrine against the uncomplicated Plasmodium falciparum malaria in Metema district, Northwestern Ethiopia

Wudneh F, Assefa A, Nega D, Mohammed H, Solomon H, Kebede T, Woyessa A, Assefa Y, Kebede A, Kassa M

Therapeutics and Clinical Risk Management 2016, 12:1293-1300

Published Date: 24 August 2016

How does hospitalization affect continuity of drug therapy: an exploratory study

Blozik E, Signorell A, Reich O

Therapeutics and Clinical Risk Management 2016, 12:1277-1283

Published Date: 22 August 2016

Vojta method in the treatment of developmental hip dysplasia – a case report

Kiebzak W, Żurawski A, Dwornik M

Therapeutics and Clinical Risk Management 2016, 12:1271-1276

Published Date: 19 August 2016

Clinical management of a challenging malignancy, osteoblastoma-like osteosarcoma: a report of four cases and a review of the literature

Ozger H, Alpan B, Söylemez MS, Ozkan K, Salduz A, Bilgic B, Sirin BK

Therapeutics and Clinical Risk Management 2016, 12:1261-1270

Published Date: 17 August 2016

Prognostic indicators for failed nonsurgical reduction of intussusception

Khorana J, Singhavejsakul J, Ukarapol N, Laohapensang M, Siriwongmongkol J, Patumanond J

Therapeutics and Clinical Risk Management 2016, 12:1231-1237

Published Date: 9 August 2016

Role of isavuconazole in the treatment of invasive fungal infections

Wilson DT, Dimondi VP, Johnson SW, Jones TM, Drew RH

Therapeutics and Clinical Risk Management 2016, 12:1197-1206

Published Date: 3 August 2016

Impact of baseline systolic blood pressure on visit-to-visit blood pressure variability: the Kailuan study

Wang A, Li Z, Yang Y, Chen G, Wang C, Wu Y, Ruan C, Liu Y, Wang Y, Wu S

Therapeutics and Clinical Risk Management 2016, 12:1191-1196

Published Date: 2 August 2016

Effect of biological factors on successful measurements with skeletal-muscle 1H-MRS

Isobe T, Okamoto Y, Hirano Y, Ando H, Takada K, Sato E, Shinoda K, Tadano K, Takei H, Kamizawa S, Mori Y, Suzuki H

Therapeutics and Clinical Risk Management 2016, 12:1133-1137

Published Date: 20 July 2016

Is there a relationship between fracture healing and mean platelet volume?

Serbest S, Tiftikci U, Tosun HB, Gumustas SA, Uludag A

Therapeutics and Clinical Risk Management 2016, 12:1095-1099

Published Date: 13 July 2016

Correlation between obesity and chronic kidney disease: is obstructive sleep apnea an interfering factor?

Santos-Camilo M, Arães SP, Hirotsu C, Tufik S, Andersen ML

Therapeutics and Clinical Risk Management 2016, 12:1093-1094

Published Date: 11 July 2016

Relationship between the iceA gene of Helicobacter pylori and clinical outcomes

Huang XJ, Deng ZM, Zhang Q, Li WY, Wang BN, Li MY

Therapeutics and Clinical Risk Management 2016, 12:1085-1092

Published Date: 6 July 2016

Profile of eliglustat tartrate in the management of Gaucher disease [Corrigendum]

Sechi A, Dardis A, Bembi B

Therapeutics and Clinical Risk Management 2016, 12:1083-1084

Published Date: 7 July 2016

Role of biologics in severe eosinophilic asthma – focus on reslizumab

Pelaia G, Vatrella A, Busceti MT, Gallelli L, Preianò M, Lombardo N, Terracciano R, Maselli R

Therapeutics and Clinical Risk Management 2016, 12:1075-1082

Published Date: 1 July 2016

Papillary thyroid carcinoma risk factors in the Yunnan plateau of southwestern China

Zeng R, Shou T, Yang KX, Shen T, Zhang JP, Zuo RX, Zheng YQ, Yan XM

Therapeutics and Clinical Risk Management 2016, 12:1065-1074

Published Date: 30 June 2016

Atrial fibrillation is a predictor of in-hospital mortality in ischemic stroke patients

Ong CT, Wong YS, Wu CS, Su YH

Therapeutics and Clinical Risk Management 2016, 12:1057-1064

Published Date: 29 June 2016

The Oxfordshire Community Stroke Project classification system predicts clinical outcomes following intravenous thrombolysis: a prospective cohort study

Yang Y, Wang A, Zhao X, Wang C, Liu L, Zheng H, Wang Y, Cao Y, Wang Y

Therapeutics and Clinical Risk Management 2016, 12:1049-1056

Published Date: 29 June 2016

True anteroposterior view pedicle screw insertion technique

Bai JY, Zhang W, An JL, Sun YP, Ding WY, Shen Y

Therapeutics and Clinical Risk Management 2016, 12:1039-1047

Published Date: 29 June 2016

Syncope as a presentation of acute pulmonary embolism

Altınsoy B, Erboy F, Tanrıverdi H, Uygur F, Örnek T, Atalay F, Tor M

Therapeutics and Clinical Risk Management 2016, 12:1023-1028

Published Date: 27 June 2016

New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim

Ghidini M, Hahne JC, Trevisani F, Panni S, Ratti M, Toppo L, Tomasello G

Therapeutics and Clinical Risk Management 2016, 12:1009-1015

Published Date: 24 June 2016

Value of cyst localization to predict cystobiliary communication in patients undergoing conservative surgery with hydatid cyst

Alan B, Kapan M, Teke M, Hattapoğlu S, Arıkanoğlu Z

Therapeutics and Clinical Risk Management 2016, 12:995-1001

Published Date: 15 June 2016

Prescription of antibiotics in community-acquired pneumonia in children: are we following the recommendations?

Fonseca Lima EJ, Lima DEP, Serra GHC, Abreu e Lima MAZS, Mello MJG

Therapeutics and Clinical Risk Management 2016, 12:983-988

Published Date: 14 June 2016

Mesalazine-induced eosinophilic pneumonia with bone marrow infiltration: a case report and literature review

Zhang Y, Luo L, Wang X, Liu X, Wang X, Ding Y

Therapeutics and Clinical Risk Management 2016, 12:975-981

Published Date: 14 June 2016

Pazopanib in the management of advanced soft tissue sarcomas

Cranmer LD, Loggers ET, Pollack SM

Therapeutics and Clinical Risk Management 2016, 12:941-955

Published Date: 9 June 2016

A case of gait disturbance caused by low-dose gabapentin

Kanao-Kanda M, Kanda H, Takahata O, Kunisawa T

Therapeutics and Clinical Risk Management 2016, 12:927-929

Published Date: 9 June 2016

Clinical usefulness of mepolizumab in severe eosinophilic asthma

Menzella F, Lusuardi M, Montanari G, Galeone C, Facciolongo N, Zucchi L

Therapeutics and Clinical Risk Management 2016, 12:907-916

Published Date: 8 June 2016

Review of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studies

Bonsu KO, Owusu IK, Buabeng KO, Reidpath DD, Kadirvelu A

Therapeutics and Clinical Risk Management 2016, 12:887-906

Published Date: 3 June 2016

Herpetic esophagitis following bendamustine-containing regimen

Yamane H, Monobe Y, Tanikawa T, Ochi N, Honda Y, Kawamoto H, Takigawa N

Therapeutics and Clinical Risk Management 2016, 12:883-886

Published Date: 2 June 2016

Growth hormone therapy for Prader–Willi syndrome: challenges and solutions

Grugni G, Sartorio A, Crinò A

Therapeutics and Clinical Risk Management 2016, 12:873-881

Published Date: 2 June 2016

The potential utilizations of hydrogen as a promising therapeutic strategy against ocular diseases

Tao Y, Geng L, Xu WW, Qin LM, Peng GH, Huang YF

Therapeutics and Clinical Risk Management 2016, 12:799-806

Published Date: 19 May 2016

Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome

Sobolewska-Włodarczyk A, Włodarczyk M, Storr M, Fichna J

Therapeutics and Clinical Risk Management 2016, 12:771-775

Published Date: 13 May 2016

Association of glutathione S-transferase T1, M1, and P1 polymorphisms in the breast cancer risk: a meta-analysis

Song ZW, Shao C, Feng C, Lu YL, Gao Y, Dong CY

Therapeutics and Clinical Risk Management 2016, 12:763-769

Published Date: 12 May 2016

The effect of interferon gamma on conventional fractionated radiation-induced damage and fibrosis in the pelvic tissue of rabbits

Yang Y, Liu Z, Wang J, Chai Y, Su J, Shi F, Wang J, Che SM

Therapeutics and Clinical Risk Management 2016, 12:755-762

Published Date: 11 May 2016

Recovery of a 10-year-old girl from methicillin-resistant Staphylococcus aureus sepsis in response to low-dose ceftaroline treatment

Borgmann S, Rieß B, Wernitz-Keibel T, Bühler M, Layer F, Strommenger B

Therapeutics and Clinical Risk Management 2016, 12:749-753

Published Date: 11 May 2016

Diagnosis and screening of patients with hereditary angioedema in primary care

Henao MP, Kraschnewski JL, Kelbel T, Craig TJ

Therapeutics and Clinical Risk Management 2016, 12:701-711

Published Date: 2 May 2016

High-intensity focused ultrasound therapy in combination with gemcitabine for unresectable pancreatic carcinoma

Lv W, Yan T, Wang G, Zhao W, Zhang T, Zhou D

Therapeutics and Clinical Risk Management 2016, 12:687-691

Published Date: 2 May 2016

Comparative risk impact of edoxaban in the management of stroke and venous thromboembolism

Tellor KB, Van Tuyl JS, Armbruster AL

Therapeutics and Clinical Risk Management 2016, 12:667-674

Published Date: 26 April 2016

Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio reliable parameters as prognostic indicators in malignant mesothelioma?

Tural Onur S, Sokucu SN, Dalar L, Iliaz S, Kara K, Buyukkale S, Altin S

Therapeutics and Clinical Risk Management 2016, 12:651-656

Published Date: 22 April 2016

Absorbable scaphoid screw development: a comparative study on biomechanics

Wang Y, Song MG, Xu YQ, He XQ, Zhu YL

Therapeutics and Clinical Risk Management 2016, 12:643-650

Published Date: 22 April 2016

Cardiac, renal, and neurological benefits of preoperative levosimendan administration in patients with right ventricular dysfunction and pulmonary hypertension undergoing cardiac surgery: evaluation with two biomarkers neutrophil gelatinase-associated lipocalin and neuronal enolase

Guerrero-Orriach JL, Ariza-Villanueva D, Florez-Vela A, Garrido-Sánchez L, Moreno-Cortés MI, Galán-Ortega M, Ramírez-Fernández A, Alcaide Torres J, Santiago Fernandez C, Navarro Arce I, Melero-Tejedor JM, Rubio-Navarro M, Cruz-Mañas J

Therapeutics and Clinical Risk Management 2016, 12:623-630

Published Date: 21 April 2016

Are the blood groups of women with preeclampsia a risk factor for the development of hypertension postpartum?

Avci D, Karagoz H, Ozer O, Esmeray K, Bulut K, Aykas F, Cetinkaya A, Uslu E, Karahan S, Basak M, Erden A

Therapeutics and Clinical Risk Management 2016, 12:617-622

Published Date: 19 April 2016

The application of nutrition support in conservative treatment of chylous ascites after abdominal surgery

Pan W, Cai SY, Luo HL, Ouyang SR, Zhang WD, Wei ZR, Wang DL

Therapeutics and Clinical Risk Management 2016, 12:607-612

Published Date: 15 April 2016

The influence of methods of bariatric surgery for treatment of type 2 diabetes mellitus

Bužga M, Maresova P, Seidlerová A, Zonča P, Holéczy P, Kuča K

Therapeutics and Clinical Risk Management 2016, 12:599-605

Published Date: 15 April 2016

Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine

Wang XY, Lim-Jurado M, Prepageran N, Tantilipikorn P, Wang DY

Therapeutics and Clinical Risk Management 2016, 12:585-597

Published Date: 13 April 2016

Application of surgical navigation in styloidectomy for treating Eagle’s syndrome

Dou G, Zhang Y, Zong CL, Chen YL, Guo YX, Tian L

Therapeutics and Clinical Risk Management 2016, 12:575-583

Published Date: 12 April 2016

Dysplasia epiphysealis hemimelica (Trevor disease) in the ankle

Ozan F, Doğar F, Gürbüz K, Ekinci Y, Bilal Ö, Öncel ES

Therapeutics and Clinical Risk Management 2016, 12:545-547

Published Date: 6 April 2016

Management of children’s acute diarrhea by community pharmacies in five towns of Ethiopia: simulated client case study

Abegaz TM, Belachew SA, Abebe TB, Gebresilassie BM, Teni FS, Woldie HG

Therapeutics and Clinical Risk Management 2016, 12:515-526

Published Date: 5 April 2016

Dysfunction of the thyroid gland during amiodarone therapy: a study of 297 cases

Czarnywojtek A, Płazińska MT, Zgorzalewicz-Stachowiak M, Woliński K, Stangierski A, Miechowicz I, Waligórska-Stachura J, Gut P, Królicki L, Zioncheck M, Ruchała M

Therapeutics and Clinical Risk Management 2016, 12:505-513

Published Date: 4 April 2016

Correlation of visceral adiposity index with chronic kidney disease in the People’s Republic of China: to rediscover the new clinical potential of an old indicator for visceral obesity

Xu XM, Zhao Y, Zhao ZH, Zhu SS, Liu XY, Zhou CM, Shao XF, Liang Y, Duan CY, Holthöfer H, Zou HQ

Therapeutics and Clinical Risk Management 2016, 12:489-494

Published Date: 29 March 2016

Guidelines for acute management of hyperammonemia in the Middle East region

Alfadhel M, Al Mutairi F, Makhseed N, Al Jasmi F, Al-Thihli K, Al-Jishi E, AlSayed M, Al-Hassnan ZN, Al-Murshedi F, Häberle J, Ben-Omran T

Therapeutics and Clinical Risk Management 2016, 12:479-487

Published Date: 31 March 2016

The impact of oxidized serum albumin on the oncotic pressure and hydration status of peritoneal dialysis patients

Hassan K, Kristal B, Hassan F, Abo Saleh S, Michelis R

Therapeutics and Clinical Risk Management 2016, 12:463-469

Published Date: 24 March 2016

Post-stroke bacteriuria among stroke patients attending a physiotherapy clinic in Ghana: a cross-sectional study

Donkor ES, Akumwena A, Amoo PK, Owolabi MO, Aspelund T, Gudnason V

Therapeutics and Clinical Risk Management 2016, 12:457-462

Published Date: 17 March 2016

Development and novel therapeutics in hepatocellular carcinoma: a review

Ingle PV, Samsudin SZ, Chan PQ, Ng MK, Heng LX, Yap SC, Chai ASH, Wong ASY

Therapeutics and Clinical Risk Management 2016, 12:445-455

Published Date: 16 March 2016

Prevalence of diabetes and determinants: evidence from a minority region in People’s Republic of China

Chen Q, Yi Y, Xia N, Li C, Luo Z, Huang G, Chen Y, Li S, Lai L, Wang M, Tan J, Zhang J, Shen H, Li B, Su F, Wei H, Dai X, Lu F, Li S

Therapeutics and Clinical Risk Management 2016, 12:427-433

Published Date: 14 March 2016

Concentrated insulins: the new basal insulins

Lamos EM, Younk LM, Davis SN

Therapeutics and Clinical Risk Management 2016, 12:389-400

Published Date: 9 March 2016

Allergic diseases among children: nutritional prevention and intervention

Hendaus MA, Jomha FA, Ehlayel M

Therapeutics and Clinical Risk Management 2016, 12:361-372

Published Date: 7 March 2016

Evaluation of safety and efficacy of zonisamide in adult patients with partial, generalized, and combined seizures: an open labeled, noncomparative, observational Indian study

Dash A, Ravat S, Srinivasan AV, Shetty A, Kumar V, Achtani R, Mathur VN, Maramattom BV, Bajpai V, Manjunath NC, Narayana RV, Mehta S

Therapeutics and Clinical Risk Management 2016, 12:327-334

Published Date: 29 February 2016

Clinical utility of nivolumab in the treatment of advanced melanoma

Asmar R, Yang J, Carvajal RD

Therapeutics and Clinical Risk Management 2016, 12:313-325

Published Date: 26 February 2016

Ethyl pyruvate protects against sepsis by regulating energy metabolism

Kang H, Mao Z, Zhao Y, Yin T, Song Q, Pan L, Hu X, Hu J, Zhou F

Therapeutics and Clinical Risk Management 2016, 12:287-294

Published Date: 23 February 2016

Effect of red yeast rice combined with antioxidants on lipid pattern, hs-CRP level, and endothelial function in moderately hypercholesterolemic subjects

Cicero AF, Morbini M, Parini A, Urso R, Rosticci M, Grandi E, Borghi C

Therapeutics and Clinical Risk Management 2016, 12:281-286

Published Date: 23 February 2016

Is ketamine a lifesaving agent in childhood acute severe asthma?

Hendaus MA, Jomha FA, Alhammadi AH

Therapeutics and Clinical Risk Management 2016, 12:273-279

Published Date: 22 February 2016

Drug-related problems in a sample of outpatients with chronic diseases: a cross-sectional study from Jordan

Al-Azzam SI, Alzoubi KH, AbuRuz S, Alefan Q

Therapeutics and Clinical Risk Management 2016, 12:233-239

Published Date: 17 February 2016

Influence of MDR1 methylation on the curative effect of interventional embolism chemotherapy for cervical cancer

Huang Z, Zhang S, Shen YP, Liu WX, Long JP, Zhou S

Therapeutics and Clinical Risk Management 2016, 12:217-223

Published Date: 15 February 2016

New combinations in the treatment of COPD: rationale for aclidinium–formoterol

Incorvaia C, Montagni M, Makri E, Ridolo E

Therapeutics and Clinical Risk Management 2016, 12:209-215

Published Date: 15 February 2016

IgG4-related disease: current challenges and future prospects

Lang D, Zwerina J, Pieringer H

Therapeutics and Clinical Risk Management 2016, 12:189-199

Published Date: 15 February 2016

Low-back pain at the emergency department: still not being managed?

Rizzardo A, Miceli L, Bednarova R, Guadagnin GM, Sbrojavacca R, Della Rocca G

Therapeutics and Clinical Risk Management 2016, 12:183-187

Published Date: 12 February 2016

Intravitreal ketorolac for the treatment of chronic cystoid macular edema after cataract surgery

Tsilimbaris MK, Tsika C, Kymionis GD

Therapeutics and Clinical Risk Management 2016, 12:177-182

Published Date: 12 February 2016

A retrospective drug use evaluation of cabergoline for lactation inhibition at a tertiary care teaching hospital in Qatar

AlSaad D, ElSalem S, Abdulrouf PV, Thomas B, Alsaad T, Ahmad A, AlHail M

Therapeutics and Clinical Risk Management 2016, 12:155-160

Published Date: 9 February 2016

Effect of a nonsurgical treatment program on the gait pattern of idiopathic toe walking: a case report

Szopa A, Domagalska˗Szopa M, Gallert˗Kopyto W, Kiebzak W, Plinta R

Therapeutics and Clinical Risk Management 2016, 12:139-146

Published Date: 10 February 2016

Nutritional management in an elderly man with esophageal and gastric necrosis after caustic soda ingestion: a case report

Rondanelli M, Peroni G, Miccono A, Guerriero F, Guido D, Perna S

Therapeutics and Clinical Risk Management 2016, 12:129-133

Published Date: 4 February 2016

Association of nuclear and mitochondrial genes with audiological examinations in Iranian patients with nonaminoglycoside antibiotics-induced hearing loss

Balali M, Kamalidehghan B, Farhadi M, Ahmadipour F, Ashkezari MD, Hemami MR, Arabzadeh H, Falah M, Meng GY, Houshmand M

Therapeutics and Clinical Risk Management 2016, 12:117-128

Published Date: 28 January 2016

A new modified technique of laparoscopic needle catheter jejunostomy: a 2-year follow-up study

Ye P, Zeng LP, Sun FH, An Z, Li ZB, Hu J

Therapeutics and Clinical Risk Management 2016, 12:103-108

Published Date: 25 January 2016

Risk factors associated with postoperative pain after ophthalmic surgery: a prospective study

Lesin M, Dzaja Lozo M, Duplancic-Sundov Z, Dzaja I, Davidovic N, Banozic A, Puljak L

Therapeutics and Clinical Risk Management 2016, 12:93-102

Published Date: 22 January 2016

Reduction of group A beta-hemolytic streptococcus pharyngo-tonsillar infections associated with use of the oral probiotic Streptococcus salivarius K12: a retrospective observational study

Gregori G, Righi O, Risso P, Boiardi G, Demuru G, Ferzetti A, Galli A, Ghisoni M, Lenzini S, Marenghi C, Mura C, Sacchetti R, Suzzani L

Therapeutics and Clinical Risk Management 2016, 12:87-92

Published Date: 19 January 2016

The value of trabectedin in the treatment of soft tissue sarcoma

Nakamura T, Matsumine A, Sudo A

Therapeutics and Clinical Risk Management 2016, 12:73-79

Published Date: 13 January 2016

Comparison of three approaches of Bernese periacetabular osteotomy

Luo DZ, Zhang H, Zhang WJ

Therapeutics and Clinical Risk Management 2016, 12:67-72

Published Date: 12 January 2016

Video-assisted thoracic surgery reduces early postoperative stress. A single-institutional prospective randomized study

Asteriou C, Lazopoulos A, Rallis T, Gogakos AS, Paliouras D, Tsakiridis K, Zissimopoulos A, Tsavlis D, Porpodis K, Hohenforst-Schmidt W, Kioumis I, Organtzis J, Zarogoulidis K, Zarogoulidis P, Barbetakis N

Therapeutics and Clinical Risk Management 2016, 12:59-65

Published Date: 12 January 2016

Profile of eliglustat tartrate in the management of Gaucher disease

Sechi A, Dardis A, Bembi B

Therapeutics and Clinical Risk Management 2016, 12:53-58

Published Date: 11 January 2016

Particulate matter is associated with sputum culture conversion in patients with culture-positive tuberculosis

Chen KY, Chuang KJ, Liu HC, Lee KY, Feng PH, Su CL, Lin CL, Lee CN, Chuang HC

Therapeutics and Clinical Risk Management 2016, 12:41-46

Published Date: 6 January 2016

Coexistence of squamous cell tracheal papilloma and carcinoma treated with chemotherapy and radiotherapy: a case report

Paliouras D, Gogakos A, Rallis T, Chatzinikolaou F, Asteriou C, Tagarakis G, Organtzis J, Tsakiridis K, Tsavlis D, Zissimopoulos A, Kioumis I, Hohenforst-Schmidt W, Zarogoulidis K, Zarogoulidis P, Barbetakis N

Therapeutics and Clinical Risk Management 2016, 12:1-4

Published Date: 21 December 2015

USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study

Frankova S, Jirsa M, Merta D, Neroldova M, Urbanek P, Senkerikova R, Spicak J, Sperl J

Therapeutics and Clinical Risk Management 2015, 11:1853-1861

Published Date: 17 December 2015

Are atrophic long-bone nonunions associated with low-grade infections?

Dapunt U, Spranger O, Gantz S, Burckhardt I, Zimmermann S, Schmidmaier G, Moghaddam A

Therapeutics and Clinical Risk Management 2015, 11:1843-1852

Published Date: 15 December 2015

Enema reduction of intussusception: the success rate of hydrostatic and pneumatic reduction

Khorana J, Singhavejsakul J, Ukarapol N, Laohapensang M, Wakhanrittee J, Patumanond J

Therapeutics and Clinical Risk Management 2015, 11:1837-1842

Published Date: 15 December 2015

The effect of low-sodium dialysate on ambulatory blood pressure measurement parameters in patients undergoing hemodialysis

Akdag S, Akyol A, Cakmak HA, Tosu AR, Asker M, Yaman M, Babat N, Soyoral Y, Cegin MB, Gur AK, Gumrukcuoglu HA

Therapeutics and Clinical Risk Management 2015, 11:1829-1835

Published Date: 11 December 2015

Early myocardial damage assessment in dystrophinopathies using 99Tcm-MIBI gated myocardial perfusion imaging

Zhang L, Liu Z, Hu KY, Tian QB, Wei LG, Zhao Z, Shen HR, Hu J

Therapeutics and Clinical Risk Management 2015, 11:1819-1827

Published Date: 10 December 2015

Lung ultrasound for the diagnosis of childhood pneumonia: a safe and accurate imaging mode

Hendaus MA, Jomha FA, Alhammadi AH

Therapeutics and Clinical Risk Management 2015, 11:1817-1818

Published Date: 9 December 2015

Docetaxel-related interstitial pneumonitis

Wang CJ, Chang HT, Chang CY

Therapeutics and Clinical Risk Management 2015, 11:1813-1816

Published Date: 9 December 2015

Hypercalcemia of malignancy and new treatment options

Sternlicht H, Glezerman IG

Therapeutics and Clinical Risk Management 2015, 11:1779-1788

Published Date: 4 December 2015

Profile of secukinumab in the treatment of psoriasis: current perspectives

Roman M, Madkan VK, Chiu MW

Therapeutics and Clinical Risk Management 2015, 11:1767-1777

Published Date: 2 December 2015

Bevacizumab for glioblastoma

Narita Y

Therapeutics and Clinical Risk Management 2015, 11:1759-1765

Published Date: 1 December 2015

Clinical development of nintedanib for advanced non-small-cell lung cancer

Takeda M, Okamoto I, Nakagawa K

Therapeutics and Clinical Risk Management 2015, 11:1701-1706

Published Date: 16 November 2015

Evidence-based treatments for cluster headache

Gooriah R, Buture A, Ahmed F

Therapeutics and Clinical Risk Management 2015, 11:1687-1696

Published Date: 9 November 2015

Bortezomib in mantle cell lymphoma: comparative therapeutic outcomes

Vallumsetla N, Paludo J, Kapoor P

Therapeutics and Clinical Risk Management 2015, 11:1663-1674

Published Date: 6 November 2015

The relationships between blood pressure, blood glucose, and bone mineral density in postmenopausal Turkish women

Cakmak HA, Cakmak BD, Yumru AE, Aslan S, Enhos A, Kalkan AK, Inci Coskun E, Acikgoz AS, Karatas S

Therapeutics and Clinical Risk Management 2015, 11:1641-1648

Published Date: 30 October 2015

Decompressive craniectomy for severe traumatic brain injury patients with fixed dilated pupils

Mao X, Miao G, Hao S, Tao X, Hou Z, Li H, Tian R, Zhang H, Lu T, Ma J, Zhang X, Cheng H, Liu B

Therapeutics and Clinical Risk Management 2015, 11:1627-1633

Published Date: 22 October 2015

Effect of fluid loading on left ventricular volume and stroke volume variability in patients with end-stage renal disease: a pilot study

Kanda H, Hirasaki Y, Iida T, Kanao-Kanda M, Toyama Y, Kunisawa T, Iwasaki H

Therapeutics and Clinical Risk Management 2015, 11:1619-1625

Published Date: 20 October 2015

The role of blood groups in the development of diabetes mellitus after gestational diabetes mellitus

Karagoz H, Erden A, Ozer O, Esmeray K, Cetinkaya A, Avci D, Karahan S, Basak M, Bulut K, Mutlu H, Simsek Y

Therapeutics and Clinical Risk Management 2015, 11:1613-1617

Published Date: 19 October 2015

Patterns of treatment and costs of intermediate and advanced hepatocellular carcinoma management in four Italian centers

Colombo GL, Cammà C, Attili AF, Ganga R, Gaeta GB, Brancaccio G, Franzini JM, Volpe M, Turchetti G

Therapeutics and Clinical Risk Management 2015, 11:1603-1612

Published Date: 19 October 2015

Symptomatic flexible flatfoot in adults: subtalar arthroereisis

Ozan F, Doğar F, Gençer K, Koyuncu Ş, Vatansever F, Duygulu F, Altay T

Therapeutics and Clinical Risk Management 2015, 11:1597-1602

Published Date: 16 October 2015

Mandibular bone mineral density in patients with Behçet’s disease

Asutay F, Atalay Y, Acar AH, Asutay H, Eroğlu S, Burdurlu MÇ

Therapeutics and Clinical Risk Management 2015, 11:1587-1591

Published Date: 14 October 2015

Pulse oximetry in bronchiolitis: is it needed?

Hendaus MA, Jomha FA, Alhammadi AH

Therapeutics and Clinical Risk Management 2015, 11:1573-1578

Published Date: 12 October 2015

Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD

Pelaia G, Vatrella A, Busceti MT, Gallelli L, Calabrese C, Terracciano R, Lombardo N, Maselli R

Therapeutics and Clinical Risk Management 2015, 11:1563-1572

Published Date: 8 October 2015

Prognostic nutritional index before adjuvant chemotherapy predicts chemotherapy compliance and survival among patients with non-small-cell lung cancer

Shimizu K, Okita R, Saisho S, Yukawa T, Maeda A, Nojima Y, Nakata M

Therapeutics and Clinical Risk Management 2015, 11:1555-1561

Published Date: 8 October 2015

Cigarette smoke is a risk factor for severity and treatment outcome in patients with culture-positive tuberculosis

Chuang HC, Su CL, Liu HC, Feng PH, Lee KY, Chuang KJ, Lee CN, Bien MY

Therapeutics and Clinical Risk Management 2015, 11:1539-1544

Published Date: 6 October 2015

Acute gastrointestinal injury in the intensive care unit: a retrospective study

Chen HS, Zhang HD, Li W, Wu SN, Wang W

Therapeutics and Clinical Risk Management 2015, 11:1523-1529

Published Date: 5 October 2015

Anatomic and functional outcomes of retinectomy for the management of complicated retinal detachment with proliferative vitreoretinopathy

Tranos P, Vakalis A, Asteriadis S, Lokovitis E, Georgalas I, Stravrakas P

Therapeutics and Clinical Risk Management 2015, 11:1515-1521

Published Date: 3 October 2015

The potential of medical device industry in technological and economical context

Maresova P, Penhaker M, Selamat A, Kuca K

Therapeutics and Clinical Risk Management 2015, 11:1505-1514

Published Date: 3 October 2015

Surveillance of antibiotic and analgesic use in the Oral Surgery Department of the University Dentistry Clinical Center of Kosovo

Haliti NR, Haliti FR, Koçani FK, Gashi AA, Mrasori SI, Hyseni VI, Bytyqi SI, Krasniqi LL, Murtezani AF, Krasniqi SL

Therapeutics and Clinical Risk Management 2015, 11:1497-1503

Published Date: 1 October 2015

Bivalirudin plus loading dose of cilostazol-based triple-antiplatelet in treatment of non-ST-elevation myocardial infarction following percutaneous coronary intervention

Wang M, Zhang GR, Wang YL, Zhou K, Liu T, Zhang Y, Guo AJ, An Y, Zhang XD, Li YJ

Therapeutics and Clinical Risk Management 2015, 11:1469-1473

Published Date: 28 September 2015

Emerging therapeutic options for sporadic inclusion body myositis

Alfano LN, Lowes LP

Therapeutics and Clinical Risk Management 2015, 11:1459-1467

Published Date: 25 September 2015

Diagnosis and management of miliary tuberculosis: current state and future perspectives [Retraction]

Ray S, Talukdar A, Kundu S, Khanra D, Sonthalia N

Therapeutics and Clinical Risk Management 2015, 11:1457-1458

Published Date: 28 September 2015

Tumor necrosis factor-alpha G-238A polymorphism and coronary artery disease risk: a meta-analysis of 4,222 patients and 4,832 controls

Hua XP, Zhang XD, Kwong JS, Zeng XT, Zhang ZJ, Wei WL

Therapeutics and Clinical Risk Management 2015, 11:1429-1436

Published Date: 23 September 2015

The clinical application of linagliptin in Asians

Cao CQ, Xiang YF, Zhou ZG

Therapeutics and Clinical Risk Management 2015, 11:1409-1419

Published Date: 16 September 2015

New advances in the treatment of generalized lipodystrophy: role of metreleptin

Rodriguez AJ, Mastronardi CA, Paz-Filho GJ

Therapeutics and Clinical Risk Management 2015, 11:1391-1400

Published Date: 16 September 2015

Perioperative management of hemophilia patients receiving total hip and knee arthroplasty: a complication report of two cases

Tateiwa T, Takahashi Y, Ishida T, Kubo K, Masaoka T, Shishido T, Sano K, Yamamoto K

Therapeutics and Clinical Risk Management 2015, 11:1383-1389

Published Date: 15 September 2015

Aldehyde dehydrogenase-2 protects against myocardial infarction-related cardiac fibrosis through modulation of the Wnt/β-catenin signaling pathway

Zhao XJ, Hua Y, Chen HM, Yang HY, Zhang T, Huang GQ, Fan HJ, Tan ZB, Huang XF, Liu B, Zhou YC

Therapeutics and Clinical Risk Management 2015, 11:1371-1381

Published Date: 11 September 2015

A case series of pregnancy- and lactation-associated osteoporosis and a review of the literature

Nakamura Y, Kamimura M, Ikegami S, Mukaiyama K, Komatsu M, Uchiyama S, Kato H

Therapeutics and Clinical Risk Management 2015, 11:1361-1365

Published Date: 7 September 2015

The role of SDF-1/CXCR4 in the vasculogenesis and remodeling of cerebral arteriovenous malformation

Wang L, Guo S, Zhang N, Tao Y, Zhang H, Qi T, Liang F, Huang Z

Therapeutics and Clinical Risk Management 2015, 11:1337-1344

Published Date: 1 September 2015

Efficacy of biological agents administered as monotherapy in rheumatoid arthritis: a Bayesian mixed-treatment comparison analysis

Migliore A, Bizzi E, Egan CG, Bernardi M, Petrella L

Therapeutics and Clinical Risk Management 2015, 11:1325-1335

Published Date: 1 September 2015

National consumption of opioid and nonopioid analgesics in Croatia: 2007–2013

Krnic D, Anic-Matic A, Dosenovic S, Draganic P, Zezelic S, Puljak L

Therapeutics and Clinical Risk Management 2015, 11:1305-1314

Published Date: 28 August 2015

Validity of subjective smoking status in orthopedic patients

Bender D, Haubruck P, Boxriker S, Korff S, Schmidmaier G, Moghaddam A

Therapeutics and Clinical Risk Management 2015, 11:1297-1303

Published Date: 27 August 2015

Tracheobronchial foreign bodies in children – a retrospective study of 2,000 cases in Northwestern China

Liang JM, Hu J, Chang HM, Gao Y, Luo HN, Wang ZH, Zheng GX, Chen F, Wang T, Yang YY, Kou XH, Xu M

Therapeutics and Clinical Risk Management 2015, 11:1291-1295

Published Date: 28 August 2015

Serotonin reuptake inhibitors and post-gastrostomy bleeding: reevaluating the link

Patel H, Gaduputi V, Sakam S, Kumar K, Chime C, Balar B

Therapeutics and Clinical Risk Management 2015, 11:1283-1289

Published Date: 27 August 2015

Virus-induced secondary bacterial infection: a concise review

Hendaus MA, Jomha FA, Alhammadi AH

Therapeutics and Clinical Risk Management 2015, 11:1265-1271

Published Date: 24 August 2015

Value of serial platelet indices measurements for the prediction of pulmonary embolism in patients with deep venous thrombosis

Sevuk U, Bahadir MV, Altindag R, Baysal E, Yaylak B, Ay N, Ayaz F, Demirtas E

Therapeutics and Clinical Risk Management 2015, 11:1243-1249

Published Date: 20 August 2015

Patient considerations in the management of ulcerative colitis – role of vedolizumab

Kothari M, Mudireddy P, Swaminath A

Therapeutics and Clinical Risk Management 2015, 11:1235-1242

Published Date: 19 August 2015

Pulmonary hypertension: diagnostic and therapeutic challenges

Bazan IS, Fares WH

Therapeutics and Clinical Risk Management 2015, 11:1221-1233

Published Date: 17 August 2015

Appendectomy in a child with cyclic neutropenia in profound neutropenic episode

Glavan N, Roganović J, Glavan-Gačanin L, Jonjić N

Therapeutics and Clinical Risk Management 2015, 11:1217-1219

Published Date: 17 August 2015

The relationship between eosinophilia and slow coronary flow

Altas Y, Kurtoglu E, Yaylak B, Baysal E, Ucaman B, Ugurlu HM, Karahan MZ, Altintas B, Adiyaman MS, Kaya İ, Erdolu U, Ozen K, Cakir C, Sevuk U

Therapeutics and Clinical Risk Management 2015, 11:1187-1191

Published Date: 12 August 2015

Xerostomia induced by radiotherapy

Alimi D

Therapeutics and Clinical Risk Management 2015, 11:1149-1152

Published Date: 5 August 2015

The appropriate troponin T level associated with coronary occlusions in chronic kidney disease patients

Sittichanbuncha Y, Sricharoen P, Tangkulpanich P, Sawanyawisuth K

Therapeutics and Clinical Risk Management 2015, 11:1143-1147

Published Date: 4 August 2015

Cesarean scar pregnancy treated by curettage and aspiration guided by laparoscopy

Shu S, Luo X, Wang Z, Yao Y

Therapeutics and Clinical Risk Management 2015, 11:1139-1141

Published Date: 3 August 2015

Fluid accumulation threshold measured by acute body weight change after admission in general surgical intensive care units: how much should be concerning?

Chittawatanarat K, Pichaiya T, Chandacham K, Jirapongchareonlap T, Chotirosniramit N

Therapeutics and Clinical Risk Management 2015, 11:1097-1106

Published Date: 27 July 2015

Paclitaxel reduces formation of hypertrophic scars in the rabbit ear model

Huang LP, Wang GQ, Jia ZS, Chen JW, Wang G, Wang XL

Therapeutics and Clinical Risk Management 2015, 11:1089-1095

Published Date: 27 July 2015

Adverse drug reactions and drug–drug interactions with over-the-counter NSAIDs

Moore N, Pollack C, Butkerait P

Therapeutics and Clinical Risk Management 2015, 11:1061-1075

Published Date: 15 July 2015

Vasopressors in septic shock: a systematic review and network meta-analysis

Zhou FH, Mao Z, Zeng XT, Kang HJ, Liu H, Pan L, Hou PC

Therapeutics and Clinical Risk Management 2015, 11:1047-1059

Published Date: 14 July 2015

Adverse reaction to ceftriaxone in a 28-day-old infant undergoing urgent craniotomy due to epidural hematoma: review of neonatal biliary pseudolithiasis

Bartkowska-Śniatkowska A, Jończyk-Potoczna K, Zielińska M, Rosada-Kurasińska J

Therapeutics and Clinical Risk Management 2015, 11:1035-1041

Published Date: 2 July 2015

Presepsin as a diagnostic marker for sepsis: evidence from a bivariate meta-analysis

Tong X, Cao Y, Yu M, Han C

Therapeutics and Clinical Risk Management 2015, 11:1027-1033

Published Date: 2 July 2015

Comparative study on drug safety surveillance between medical students of Malaysia and Nigeria

Abubakar AR, Ismail S, Rahman NIA, Haque M

Therapeutics and Clinical Risk Management 2015, 11:1015-1025

Published Date: 30 June 2015

OnabotulinumtoxinA for chronic migraine: a critical appraisal

Gooriah R, Ahmed F

Therapeutics and Clinical Risk Management 2015, 11:1003-1013

Published Date: 29 June 2015

Canagliflozin-induced pancreatitis: a rare side effect of a new drug

Chowdhary M, Kabbani AA, Chhabra A

Therapeutics and Clinical Risk Management 2015, 11:991-994

Published Date: 26 June 2015

Optimal management of digital ulcers in systemic sclerosis

Abraham S, Steen V

Therapeutics and Clinical Risk Management 2015, 11:939-947

Published Date: 15 June 2015

Staphylococcus aureus bacteremias following liver transplantation: a clinical analysis of 20 cases

Zhou JD, Huang H, Liu S, Yu P, Wan QQ

Therapeutics and Clinical Risk Management 2015, 11:933-937

Published Date: 12 June 2015

GLP-1 reduces metalloproteinase-9 induced by both hyperglycemia and hypoglycemia in type 1 diabetes. The possible role of oxidative stress

Ceriello A, La Sala L, De Nigris V, Pujadas G, Rondinelli M, Genovese S

Therapeutics and Clinical Risk Management 2015, 11:901-903

Published Date: 4 June 2015

Two cases of Paget’s disease of scrotum in biological brothers

Rao D, Zhu H, Yu K, Yu H, Xie L

Therapeutics and Clinical Risk Management 2015, 11:885-887

Published Date: 27 May 2015

Novel targeted therapies in chordoma: an update

Di Maio S, Yip S, Al Zhrani GA, Alotaibi FE, Al Turki A, Kong E, Rostomily R

Therapeutics and Clinical Risk Management 2015, 11:873-883

Published Date: 26 May 2015

Transtracheal single-point stent fixation in posttracheotomy tracheomalacia under cone-beam computer tomography guidance by transmural suturing with the Berci needle – a perspective on a new tool to avoid stent migration of Dumon stents

Hohenforst-Schmidt W, Linsmeier B, Zarogoulidis P,Freitag L, Darwiche K, Browning R, Turner JF, Huang H, Li Q, Vogl T, Zarogoulidis K, Brachmann J, Rittger H

Therapeutics and Clinical Risk Management 2015, 11:837-850

Published Date: 22 May 2015

Functional and histological improvement after everolimus rescue of chronic allograft dysfunction in renal transplant recipients

Chow KM, Szeto CC, Lai FM, Luk CC, Kwan BC, Leung CB, Li PK

Therapeutics and Clinical Risk Management 2015, 11:829-835

Published Date: 19 May 2015

Testosterone levels of children with a diagnosis of developmental stuttering

Selçuk EB, Erbay LG, Özcan ÖÖ, Kartalcı S, Batcıoğlu K

Therapeutics and Clinical Risk Management 2015, 11:793-798

Published Date: 14 May 2015

To what extent is clinical and laboratory information used to perform medication reviews in the nursing home setting? the CLEAR study

Mestres Gonzalvo C, Hurkens KPGM, de Wit HAJM, van Oijen BPC, Janknegt R, Schols JMGA, Mulder WJ, Verhey FR, Winkens B, van der Kuy PHM

Therapeutics and Clinical Risk Management 2015, 11:767-777

Published Date: 8 May 2015

Refractory cachexia is associated with increased plasma concentrations of fentanyl in cancer patients

Suno M, Endo Y, Nishie H, Kajizono M, Sendo T, Matsuoka J

Therapeutics and Clinical Risk Management 2015, 11:751-757

Published Date: 8 May 2015

Recurrent respiratory papillomatosis: current and future perspectives

Carifi M, Napolitano D, Morandi M, Dall’Olio D

Therapeutics and Clinical Risk Management 2015, 11:731-738

Published Date: 5 May 2015

Update on the management of chemotherapy-induced nausea and vomiting – focus on palonosetron

Zhou M, Popovic M, Pasetka M, Pulenzas N, Ahrari S, Chow E, DeAngelis C

Therapeutics and Clinical Risk Management 2015, 11:713-729

Published Date: 5 May 2015

Optimal management of constipation associated with irritable bowel syndrome

Furnari M, de Bortoli N, Martinucci I, Bodini G, Revelli M, Marabotto E, Moscatelli A, Del Nero L, Savarino E, Giannini EG, Savarino V

Therapeutics and Clinical Risk Management 2015, 11:691-703

Published Date: 30 April 2015

Serous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myeloma

Dogan B, Erol MK, Toslak D, Coban DT, Bulut M, Cengiz A, Sarı ES

Therapeutics and Clinical Risk Management 2015, 11:683-689

Published Date: 30 April 2015

Low-density lipoprotein cholesterol of less than 70 mg/dL is associated with fewer cardiovascular events in acute coronary syndrome patients: a real-life cohort in Thailand

Chinwong D, Patumanond J, Chinwong S, Siriwattana K, Gunaparn S, Hall JJ, Phrommintikul A

Therapeutics and Clinical Risk Management 2015, 11:659-667

Published Date: 24 April 2015

Evaluation of the appropriate use of commonly prescribed fluoroquinolones and the risk of dysglycemia

Kabbara WK, Ramadan WH, Rahbany P, Al-Natour S

Therapeutics and Clinical Risk Management 2015, 11:639-647

Published Date: 22 April 2015

Adalimumab in the management of Behçet’s disease

Ueda A, Takeno M, Ishigatsubo Y

Therapeutics and Clinical Risk Management 2015, 11:611-619

Published Date: 13 April 2015

A randomized crossover study comparing trehalose/hyaluronate eyedrops and standard treatment: patient satisfaction in the treatment of dry eye syndrome

Pinto-Bonilla JC, del Olmo-Jimeno A, Llovet-Osuna F, Hernández-Galilea E

Therapeutics and Clinical Risk Management 2015, 11:595-603

Published Date: 13 April 2015

Copeptin: a new predictor for severe obstructive sleep apnea

Çınarka H, Kayhan S, Karataş M, Yavuz A, Gümüş A, Özyurt S, Cüre MC, Şahin Ü

Therapeutics and Clinical Risk Management 2015, 11:589-594

Published Date: 10 April 2015

Pneumoscrotum: report of two different cases and review of the literature

Cochetti G, Barillaro F, Cottini E, D’Amico F, Pansadoro A, Pohja S, Boni A, Cirocchi R, Grassi V, Mancuso R, Silvi E, Ioannidou K, Egidi MG, Poli G, Mearini E

Therapeutics and Clinical Risk Management 2015, 11:581-587

Published Date: 9 April 2015

Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unit

Maggiore C, Vazquez JA, Guervil DJ, Ramani A, Jandourek A, Cole P, Friedland HD

Therapeutics and Clinical Risk Management 2015, 11:557-563

Published Date: 2 April 2015

Alemtuzumab for the treatment of multiple sclerosis

Willis MD, Robertson NP

Therapeutics and Clinical Risk Management 2015, 11:525-534

Published Date: 31 March 2015

The unsolved case of “bone-impairing analgesics”: the endocrine effects of opioids on bone metabolism

Coluzzi F, Pergolizzi J, Raffa RB, Mattia C

Therapeutics and Clinical Risk Management 2015, 11:515-523

Published Date: 31 March 2015

P-wave and QT dispersion in patients with conversion disorder

Izci F, Hocagil H, Izci S, Izci V, Koc MI, Acar RD

Therapeutics and Clinical Risk Management 2015, 11:475-480

Published Date: 26 March 2015

Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy

Wang ZY, Chen M, Zhu LL, Yu LS, Zeng S, Xiang MX, Zhou Q

Therapeutics and Clinical Risk Management 2015, 11:449-467

Published Date: 19 March 2015

Clinical use of pasireotide for Cushing's disease in adults

Ceccato F, Scaroni C, Boscaro M

Therapeutics and Clinical Risk Management 2015, 11:425-434

Published Date: 17 March 2015

Long-term safety and efficacy of tobramycin in the management of cystic fibrosis

Vázquez-Espinosa E, Girón RM, Gómez-Púnter RM, García-Castillo E, Valenzuela C, Cisneros C, Zamora E, García-Pérez FJ, Ancochea J

Therapeutics and Clinical Risk Management 2015, 11:407-415

Published Date: 12 March 2015

Risk factors for osteoporosis in Japan: is it associated with Helicobacter pylori?

Asaoka D, Nagahara A, Shimada Y, Matsumoto K, Ueyama H, Matsumoto K, Nakagawa Y, Takeda T, Tanaka I, Sasaki H, Osada T, Hojo M, Watanabe S

Therapeutics and Clinical Risk Management 2015, 11:381-391

Published Date: 6 March 2015

Update on therapeutic management of idiopathic pulmonary fibrosis

Tzouvelekis A, Bonella F, Spagnolo P

Therapeutics and Clinical Risk Management 2015, 11:359-370

Published Date: 3 March 2015

Risk of breast cancer recurrence in patients receiving manual lymphatic drainage: a hospital-based cohort study

Hsiao PC, Liu JT, Lin CL, Chou W, Lu SR

Therapeutics and Clinical Risk Management 2015, 11:349-358

Published Date: 27 February 2015

Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a review

Aguirre Valadez J, García Juárez I, Rincón Pedrero R, Torre A

Therapeutics and Clinical Risk Management 2015, 11:329-338

Published Date: 27 February 2015

Role of physiotherapy and patient education in lymphedema control following breast cancer surgery

Lu SR, Hong RB, Chou W, Hsiao PC

Therapeutics and Clinical Risk Management 2015, 11:319-327

Published Date: 25 February 2015

Clinical use of azelnidipine in the treatment of hypertension in Chinese patients

Chen BL, Zhang YZ, Luo JQ, Zhang W

Therapeutics and Clinical Risk Management 2015, 11:309-318

Published Date: 24 February 2015

Optimal management of Ménière’s disease

Foster CA

Therapeutics and Clinical Risk Management 2015, 11:301-307

Published Date: 25 February 2015

Advances in diagnosis and treatment of trigeminal neuralgia

Montano N, Conforti G, Di Bonaventura R, Meglio M, Fernandez E, Papacci F

Therapeutics and Clinical Risk Management 2015, 11:289-299

Published Date: 24 February 2015

Effect of vitamin D therapy on interleukin-6, visfatin, and hyaluronic acid levels in chronic hepatitis C Egyptian patients

Sabry D, Al-Ghussein MAS, Hamdy G, Abul-Fotouh A, Motawi T, El Kazaz AY, Eldemery A, Shaker M

Therapeutics and Clinical Risk Management 2015, 11:279-288

Published Date: 19 February 2015

Reducing drug–herb interaction risk with a computerized reminder system

Lin SS, Tsai CL, Tu CY, Hsieh CL

Therapeutics and Clinical Risk Management 2015, 11:247-253

Published Date: 16 February 2015

PSCA rs2294008 C > T polymorphism contributes to gastric and bladder cancer risk

Wang M, Wang XJ, Ma YF, Ma XB, Dai ZM, Lv Y, Lin S, Liu XH, Yang PT, Dai ZJ

Therapeutics and Clinical Risk Management 2015, 11:237-245

Published Date: 13 February 2015

Echocardiographic assessment of left ventricular function in thyrotoxicosis and implications for the therapeutics of thyrotoxic cardiac disease

Anakwue RC, Onwubere BJ, Ikeh V, Anisiuba B, Ike S, Anakwue AC

Therapeutics and Clinical Risk Management 2015, 11:189-200

Published Date: 5 February 2015

Comparative efficacy and safety of local and systemic methotrexate injection in cesarean scar pregnancy

Peng P, Gui T, Liu X, Chen W, Liu Z

Therapeutics and Clinical Risk Management 2015, 11:137-142

Published Date: 27 January 2015

Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency

Chinwong D, Patumanond J, Chinwong S, Siriwattana K, Gunaparn S, Hall JJ, Phrommintikul A

Therapeutics and Clinical Risk Management 2015, 11:127-136

Published Date: 23 January 2015

Neural circuits in anxiety and stress disorders: a focused review

Duval ER, Javanbakht A, Liberzon I

Therapeutics and Clinical Risk Management 2015, 11:115-126

Published Date: 23 January 2015

Target-controlled infusion and population pharmacokinetics of landiolol hydrochloride in patients with peripheral arterial disease

Kunisawa T, Yamagishi A, Suno M, Nakade S, Honda N, Kurosawa A, Sugawara A, Tasaki Y, Iwasaki H

Therapeutics and Clinical Risk Management 2015, 11:107-114

Published Date: 17 January 2015

Tapentadol extended release in the management of peripheral diabetic neuropathic pain

Vadivelu N, Kai A, Maslin B, Kodumudi G, Legler A, Berger JM

Therapeutics and Clinical Risk Management 2015, 11:95-105

Published Date: 14 January 2015

Effect of combination tablets containing amlodipine 10 mg and irbesartan 100 mg on blood pressure and cardiovascular risk factors in patients with hypertension

Yagi S, Takashima A, Mitsugi M, Wada T, Hotchi J, Aihara K, Hara T, Ishida M, Fukuda D, Ise T, Yamaguchi K, Tobiume T, Iwase T, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Akaike M, Sata M

Therapeutics and Clinical Risk Management 2015, 11:83-88

Published Date: 12 January 2015

Management of bipolar I depression: clinical utility of lurasidone

Findlay LJ, El-Mallakh P, El-Mallakh RS

Therapeutics and Clinical Risk Management 2015, 11:75-81

Published Date: 8 January 2015

Rhegmatogenous retinal detachment due to a macular hole in a patient with pars planitis: a case report

Stavrakas P, Androu AA, Tranos P, Kontou E, Milia M, Georgalas I

Therapeutics and Clinical Risk Management 2015, 11:59-61

Published Date: 30 December 2014

The effect of nonsurgical periodontal treatment on serum and saliva chitotriosidase activities in patients with periodontitis and coronary artery disease

Bal MV, Olgun A, Abaslı D, Özdemir A. Kürşaklıoğlu H, Göktepe AS, Kurt Í

Therapeutics and Clinical Risk Management 2015, 11:53-58

Published Date: 30 December 2014

Diagnosis and management of xerostomia and hyposalivation

Villa A, Connell CL, Abati S

Therapeutics and Clinical Risk Management 2015, 11:45-51

Published Date: 22 December 2014

Treatment of adult-onset Still’s disease: a review

Jamilloux Y, Gerfaud-Valentin M, Henry T, Sève P

Therapeutics and Clinical Risk Management 2015, 11:33-43

Published Date: 22 December 2014

Bayesian imperfect information analysis for clinical recurrent data

Chang CK, Chang CC

Therapeutics and Clinical Risk Management 2015, 11:17-26

Published Date: 19 December 2014

Patient risk factors for developing a drug-related problem in a cardiology ward

Urbina O, Ferrández O, Luque S, Grau S, Mojal S, Pellicer R, Riu M, Salas E, Comin-Colet J

Therapeutics and Clinical Risk Management 2015, 11:9-15

Published Date: 17 December 2014

Trabectedin for advanced soft tissue sarcomas: optimizing use

Reid A, Martin-Liberal J, Benson C

Therapeutics and Clinical Risk Management 2014, 10:1003-1011

Published Date: 12 December 2014

Prospective study of incidence and predictors of peripheral intravenous catheter-induced complications

Abolfotouh MA, Salam M, Bani-Mustafa A, White D, Balkhy HH

Therapeutics and Clinical Risk Management 2014, 10:993-1001

Published Date: 8 December 2014

Low perfusion index affects the difference in glucose level between capillary and venous blood

Acar N, Ozcelik H, Cevik AA, Ozakin E, Yorulmaz G, Kebapci N, Bilge U, Bilgin M

Therapeutics and Clinical Risk Management 2014, 10:985-991

Published Date: 20 November 2014

Vulnerable COPD patients with comorbidities: the role of roflumilast

Lipari M, Kale-Pradhan PB

Therapeutics and Clinical Risk Management 2014, 10:969-976

Published Date: 18 November 2014

Risk of Essure microinsert abdominal migration: case report and review of literature

Ricci G, Restaino S, Di Lorenzo G, Fanfani F, Scrimin F, Mangino FP

Therapeutics and Clinical Risk Management 2014, 10:963-968

Published Date: 17 November 2014

Cardiorenal syndrome type 2: from diagnosis to optimal management

De Vecchis R, Baldi C

Therapeutics and Clinical Risk Management 2014, 10:949-961

Published Date: 12 November 2014

Acceleration training for managing nonalcoholic fatty liver disease: a pilot study

Oh S, Shida T, Sawai A, Maruyama T, Eguchi K, Isobe T, Okamoto Y, Someya N, Tanaka K, Arai E, Tozawa A, Shoda J

Therapeutics and Clinical Risk Management 2014, 10:925-936

Published Date: 7 November 2014

Meta-analysis of oral contraceptives and rheumatoid arthritis risk in women

Qi S, Xin R, Guo WN, Liu Y

Therapeutics and Clinical Risk Management 2014, 10:915-923

Published Date: 4 November 2014

Clinical and economic studies of eptifibatide in coronary stenting [Corrigendum]

Pasala T, Sattayaprasert P, Bhat PK, Athappan G, Gandhi S

Therapeutics and Clinical Risk Management 2014, 10:913-914

Published Date: 28 October 2014

Engineering practice variation through provider agreement: a cluster-randomized feasibility trial

McCarren M, Twedt EL, Mansuri FM, Nelson PR, Peek BT

Therapeutics and Clinical Risk Management 2014, 10:905-912

Published Date: 28 October 2014

Schizophrenia relapse after stopping olanzapine treatment during pregnancy: a case report

Ifteni P, Moga MA, Burtea V, Correll CU

Therapeutics and Clinical Risk Management 2014, 10:901-904

Published Date: 23 October 2014

Lobomycosis: epidemiology, clinical presentation, and management options

Francesconi VA, Klein AP, Santos AP, Ramasawmy R, Francesconi F

Therapeutics and Clinical Risk Management 2014, 10:851-860

Published Date: 9 October 2014

Prevalence of conventional risk factors and lipid profiles in patients with acute coronary syndrome and significant coronary disease

González-Pacheco H, Vargas-Barrón J, Vallejo M, Piña-Reyna Y, Altamirano-Castillo A, Sánchez-Tapia P, Martínez-Sánchez C

Therapeutics and Clinical Risk Management 2014, 10:815-823

Published Date: 6 October 2014

JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level

Lanzillo R, Liuzzi R, Vallefuoco L, Moccia M, Amato L, Vacca G, Vacchiano V, Portella G, Brescia Morra V

Therapeutics and Clinical Risk Management 2014, 10:807-814

Published Date: 9 October 2014

The dexmedetomidine concentration required after remifentanil anesthesia is three-fold higher than that after fentanyl anesthesia or that for general sedation in the ICU

Kunisawa T, Fujimoto K, Kurosawa A, Nagashima M, Matsui K, Hayashi D, Yamamoto K, Goto Y, Akutsu H, Iwasaki H

Therapeutics and Clinical Risk Management 2014, 10:797-806

Published Date: 4 October 2014

Effects of hyperbaric oxygenation therapy on symptomatic pneumocephalus

Paiva WS, Andrade AF, Figueiredo EG, Amorim RL, Prudente M, Teixeira MJ

Therapeutics and Clinical Risk Management 2014, 10:769-773

Published Date: 6 October 2014

Clinical management and therapeutic outcome of infertile couples in southeast Nigeria

Menuba IE, Ugwu EO, Obi SN, Lawani LO, Onwuka CI

Therapeutics and Clinical Risk Management 2014, 10:763-768

Published Date: 1 October 2014

Bloodstream infections in patients with hematological malignancies: which is more fatal – cancer or resistant pathogens?

Gedik H, Şimşek F, Kantürk A, Yildirmak T, Arica D, Aydin D, Demirel N, Yokuş O

Therapeutics and Clinical Risk Management 2014, 10:743-752

Published Date: 17 September 2014

Application of caspofungin in China compared with amphotericin B and fluconazole

Zhang CY, Cheng JY, Jiang Y, Liu JY

Therapeutics and Clinical Risk Management 2014, 10:737-741

Published Date: 10 September 2014

Therapeutic implications of Epstein–Barr virus infection for the treatment of nasopharyngeal carcinoma

Hutajulu SH, Kurnianda J, Tan IB, Middeldorp JM

Therapeutics and Clinical Risk Management 2014, 10:721-736

Published Date: 5 September 2014

Magnetoledtherapy in the treatment of wounds after surgical procedures of the knee joint

Pasek J, Pasek T, Sieroń A

Therapeutics and Clinical Risk Management 2014, 10:717-720

Published Date: 2 September 2014

Emerging treatments in type 2 diabetes: focus on canagliflozin

Rosiak M, Grzeszczak S, Kosior DA, Postuła M

Therapeutics and Clinical Risk Management 2014, 10:683-689

Published Date: 21 August 2014

Advanced prostate cancer – patient survival and potential impact of enzalutamide and other emerging therapies

Patel NK, Finianos A, Whitaker KD, Aragon-Ching JB

Therapeutics and Clinical Risk Management 2014, 10:651-664

Published Date: 16 August 2014

The role of erythropoietin stimulating agents in anemic patients with heart failure: solved and unresolved questions

Palazzuoli A, Ruocco G, Pellegrini M, De Gori C, Del Castillo G, Giordano N, Nuti R

Therapeutics and Clinical Risk Management 2014, 10:641-650

Published Date: 13 August 2014

Impact of pharmacist interventions on drug-related problems and laboratory markers in outpatients with human immunodeficiency virus infection

Molino CGRC, Carnevale RC, Rodrigues AT, Visacri MB, Moriel P, Mazzola PG

Therapeutics and Clinical Risk Management 2014, 10:631-639

Published Date: 7 August 2014

Double-balloon tamponade in the management of postpartum hemorrhage: a case series

Kavak SB, Kavak EC, Demirel I, Ilhan R

Therapeutics and Clinical Risk Management 2014, 10:615-620

Published Date: 2 August 2014

Clinical and economic studies of eptifibatide in coronary stenting

Pasala T, Sattayaprasert P, Bhat PK, Athappan G, Gandhi S

Therapeutics and Clinical Risk Management 2014, 10:603-614

Published Date: 2 August 2014

New drugs to treat multidrug-resistant tuberculosis: the case for bedaquiline

Leibert E, Danckers M, Rom WN

Therapeutics and Clinical Risk Management 2014, 10:597-602

Published Date: 29 July 2014

Optimal management of renal artery fibromuscular dysplasia

Gottsäter A, Lindblad B

Therapeutics and Clinical Risk Management 2014, 10:583-595

Published Date: 28 July 2014

HIV-associated lipodystrophy: a review from a Brazilian perspective

Alves MD, Brites C, Sprinz E

Therapeutics and Clinical Risk Management 2014, 10:559-566

Published Date: 17 July 2014

Profile of saxagliptin in the treatment of type 2 diabetes: focus on Japanese patients

Konya H, Yano Y, Matsutani S, Tsunoda T, Ikawa T, Kusunoki Y, Matsuo T, Miuchi M, Katsuno T, Hamaguchi T, Miyagawa JI, Namba M

Therapeutics and Clinical Risk Management 2014, 10:547-558

Published Date: 11 July 2014

Drug assessment by a Pharmacy and Therapeutics committee: from drug selection criteria to use in clinical practice

Lozano-Blázquez A, Calvo-Pita C, Carbajales-Álvarez M, Suárez-Gil P, Martínez-Martínez F, Calleja-Hernández MA

Therapeutics and Clinical Risk Management 2014, 10:527-535

Published Date: 9 July 2014

Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection

Gentile I, Buonomo AR, Zappulo E, Minei G, Morisco F, Borrelli F, Coppola N, Borgia G

Therapeutics and Clinical Risk Management 2014, 10:493-504

Published Date: 26 June 2014

Icosapent ethyl for the treatment of severe hypertriglyceridemia

Fares H, Lavie CJ, DiNicolantonio JJ, O’Keefe JH, Milani RV

Therapeutics and Clinical Risk Management 2014, 10:485-492

Published Date: 24 June 2014

Cost-effectiveness analysis on the use of rFSH + rLH for the treatment of anovulation in hypogonadotropic hypogonadal women

Papaleo E, Alviggi C, Colombo GL, Pisanelli C, Ripellino C, Longobardi S, Canonico PL

Therapeutics and Clinical Risk Management 2014, 10:479-484

Published Date: 25 June 2014

Managing an outpatient parenteral antibiotic therapy team: challenges and solutions

Halilovic J, Christensen CL, Nguyen HH

Therapeutics and Clinical Risk Management 2014, 10:459-465

Published Date: 18 June 2014

Nature and frequency of medication errors in a geriatric ward: an Indonesian experience

Ernawati DK, Lee YP, Hughes JD

Therapeutics and Clinical Risk Management 2014, 10:413-421

Published Date: 3 June 2014

New treatments for genotype 1 chronic hepatitis C – focus on simeprevir

Kanda T, Nakamoto S, Wu S, Yokosuka O

Therapeutics and Clinical Risk Management 2014, 10:387-394

Published Date: 24 May 2014

Radiation dose to the nodal regions during prone versus supine breast irradiation

Csenki M, Újhidy D, Cserháti A, Kahán Z, Varga Z

Therapeutics and Clinical Risk Management 2014, 10:367-372

Published Date: 21 May 2014

Rheumatoid arthritis in Jordan: a cross sectional study of disease severity and associated comorbidities

Alawneh KM, Khassawneh BY, Ayesh MH, Smadi M

Therapeutics and Clinical Risk Management 2014, 10:363-366

Published Date: 19 May 2014

Management of malignant hyperthermia: diagnosis and treatment

Schneiderbanger D, Johannsen S, Roewer N, Schuster F

Therapeutics and Clinical Risk Management 2014, 10:355-362

Published Date: 14 May 2014

Udenafil for the treatment of erectile dysfunction

Cho MC, Paick JS

Therapeutics and Clinical Risk Management 2014, 10:341-354

Published Date: 14 May 2014

Experimental study of tissue-engineered cartilage allograft with RNAi chondrocytes in vivo

Wang ZH, Li XL, He XJ, Zhang XH, Yang ZQ, Xu M, Wu BJ, Tu JB, Luo HN, Yan J

Therapeutics and Clinical Risk Management 2014, 10:335-340

Published Date: 8 May 2014

Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage

Gedik H, Şimşek F, Yıldırmak T, Kantürk A, Arıca D, Aydın D, Demirel N, Yokuş O

Therapeutics and Clinical Risk Management 2014, 10:305-312

Published Date: 28 April 2014

Acute-on-chronic liver failure: a review

Zamora Nava LE, Aguirre Valadez J, Chávez-Tapia NC, Torre A

Therapeutics and Clinical Risk Management 2014, 10:295-303

Published Date: 23 April 2014

Association between MDM2 rs 2279744 polymorphism and breast cancer susceptibility: a meta-analysis based on 9,788 cases and 11,195 controls

Gao J, Kang AJ, Lin S, Dai ZJ, Zhang SQ, Liu D, Zhao Y, Yang PT, Wang M, Wang XJ

Therapeutics and Clinical Risk Management 2014, 10:269-277

Published Date: 15 April 2014

Prediction and prevention of the first psychotic episode: new directions and opportunities

Piras S, Casu G, Casu MA, Orrù A, Ruiu S, Pilleri A, Manca G, Marchese G

Therapeutics and Clinical Risk Management 2014, 10:241-253

Published Date: 28 March 2014

Personalized therapeutics for levofloxacin: a focus on pharmacokinetic concerns

Gao CH, Yu LS, Zeng S, Huang YW, Zhou Q

Therapeutics and Clinical Risk Management 2014, 10:217-227

Published Date: 27 March 2014

“Denervation” of autonomous nervous system in idiopathic pulmonary arterial hypertension by low-dose radiation: a case report with an unexpected outcome

Hohenforst-Schmidt W, Zarogoulidis P, Oezkan F, Mahnkopf C, Grabenbauer G, Kreczy A, Bartunek R, Darwiche K, Freitag L, Li Q, Huang H, Vogl T, LePilvert P, Tsiouda T, Tsakiridis K, Zarogoulidis K, Brachmann J

Therapeutics and Clinical Risk Management 2014, 10:207-215

Published Date: 27 March 2014

Medication transitions and polypharmacy in older adults following acute care

Gamble JM, Hall JJ, Marrie TJ, Sadowski CA, Majumdar SR, Eurich DT

Therapeutics and Clinical Risk Management 2014, 10:189-196

Published Date: 19 March 2014

Therapeutic interventions to reduce the risk of progression from prediabetes to type 2 diabetes mellitus

Portero McLellan KC, Wyne K, Villagomez ET, Hsueh WA

Therapeutics and Clinical Risk Management 2014, 10:173-188

Published Date: 20 March 2014

Is hypertriglyceridemia a prognostic factor in sepsis?

Cetinkaya A, Erden A, Avci D, Karagoz H, Karahan S, Basak M, Bulut K, Gencer V, Mutlu H

Therapeutics and Clinical Risk Management 2014, 10:147-150

Published Date: 27 February 2014

Hypoxic hepatitis in cardiac intensive care unit: a study of cardiovascular risk factors, clinical course, and outcomes

Chávez-Tapia NC, Balderas-Garces BV, Meza-Meneses P, Herrera-Gomar M, García-López S, Gónzalez-Chon O, Uribe M

Therapeutics and Clinical Risk Management 2014, 10:139-145

Published Date: 25 February 2014

Pharmacy students' attitudes toward pharmaceutical care in Qatar

El Hajj MS, Hammad AS, Afifi HM

Therapeutics and Clinical Risk Management 2014, 10:121-129

Published Date: 18 February 2014

Postural pattern recognition in children with unilateral cerebral palsy

Domagalska-Szopa M, Szopa A

Therapeutics and Clinical Risk Management 2014, 10:113-120

Published Date: 17 February 2014

Actual preoperative fasting time in Brazilian hospitals: the BIGFAST multicenter study

Aguilar-Nascimento JE, Almeida Dias AL, Dock-Nascimento DB, Correia MITD, Campos ACL, Portari-Filho PE, Oliveira SS

Therapeutics and Clinical Risk Management 2014, 10:107-112

Published Date: 14 February 2014

Active axial spondyloarthritis: potential role of certolizumab pegol

Ranatunga S, Miller AV

Therapeutics and Clinical Risk Management 2014, 10:87-94

Published Date: 12 February 2014

Clinical differences between H3N2 and H1N1 influenza 2012 and lower respiratory tract infection found using a statistical classification approach

Petridis D, Zarogoulidis P, Kallianos A, Kioumis I, Trakada G, Spyratos D, Papaiwannou A, Porpodis K, Huang H, Rapti A, Hohenforst-Schmidt W, Zarogoulidis K

Therapeutics and Clinical Risk Management 2014, 10:77-86

Published Date: 7 February 2014

Risk factors for an early dialysis start in patients with diabetic nephropathy end-stage renal disease

Mizuno T, Hayashi T, Kato R, Noguchi A, Hayashi H, Yuzawa Y, Yamada S, Nagamatsu T

Therapeutics and Clinical Risk Management 2014, 10:73-76

Published Date: 30 January 2014

Risk factors for mortality in Asian Taiwanese patients with methanol poisoning

Lee CY, Chang EK, Lin JL, Weng CH, Lee SY, Juan KC, Yang HY, Lin C, Lee SH, Wang IK, Yen TH

Therapeutics and Clinical Risk Management 2014, 10:61-67

Published Date: 17 January 2014

Frequency of tuberculosis among diabetic patients in the People's Republic of China

Wang HT, Zhang J, Ji LC, You SH, Bai Y, Dai W, Wang ZY

Therapeutics and Clinical Risk Management 2014, 10:45-49

Published Date: 10 January 2014

Subfoveal choroidal thickness after photodynamic therapy in patients with acute idiopathic central serous chorioretinopathy

Dang Y, Sun X, Xu Y, Mu Y, Zhao M, Zhao J, Zhu Y, Zhang C

Therapeutics and Clinical Risk Management 2014, 10:37-43

Published Date: 9 January 2014

Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting

Colombo GL, Castagna A, Di Matteo S, Galli L, Bruno G, Poli A, Salpietro S, Carbone A, Lazzarin A

Therapeutics and Clinical Risk Management 2014, 10:9-15

Published Date: 18 December 2013

Colchicine intoxication: a report of two suicide cases

Erden A, Karagoz H, Gümüscü HH, Karahan S, Basak M, Aykas F, Bulut K, Cetinkaya A, Avci D, Poyrazoglu OK

Therapeutics and Clinical Risk Management 2013, 9:505-509

Published Date: 5 December 2013

National Drug Formulary review of statin therapeutic group using the multiattribute scoring tool

Ramli A, Aljunid SM, Sulong S, Md Yusof FA

Therapeutics and Clinical Risk Management 2013, 9:491-504

Published Date: 4 December 2013

Pseudobulbar affect: prevalence and management

Ahmed A, Simmons Z

Therapeutics and Clinical Risk Management 2013, 9:483-489

Published Date: 29 November 2013

Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study

Rossi L, Tomao F, Lo Russo G, Papa A, Zoratto F, Marzano R, Basso E, Giordani E, Verrico M, Ricci F, Pasciuti G, Francini E, Tomao S

Therapeutics and Clinical Risk Management 2013, 9:457-462

Published Date: 11 November 2013

Treatment approaches and antibiotic use for emergency dental treatment in Turkey

Kaptan RF, Haznedaroglu F, Basturk FB, Kayahan MB

Therapeutics and Clinical Risk Management 2013, 9:443-449

Published Date: 7 November 2013

Health claims database study of cyclosporine ophthalmic emulsion treatment patterns in dry eye patients

Stonecipher KG, Chia J, Onyenwenyi A, Villanueva L, Hollander DA

Therapeutics and Clinical Risk Management 2013, 9:409-415

Published Date: 25 October 2013

Eliminating the need for fasting with oral administration of bisphosphonates

Pazianas M, Abrahamsen B, Ferrari S, Russell RGG

Therapeutics and Clinical Risk Management 2013, 9:395-402

Published Date: 18 October 2013

Resolution of vitreomacular traction following intravitreal ranibizumab in cases of ocular toxoplasmosis with choroidal neovascularization

Petrou P, Georgalas I, Markomichelakis N, Vergados I, Gianakaki E, Rouvas A

Therapeutics and Clinical Risk Management 2013, 9:391-394

Published Date: 18 October 2013

Obesity detection rate among primary school students in the People's Republic of China: a meta-analysis

Jin Y, Ding L, Yao Y, Song X, Tang H, He L, Chen Y

Therapeutics and Clinical Risk Management 2013, 9:383-390

Published Date: 11 October 2013

A 6-year experience of CPR outcomes in an emergency department in Thailand

Sittichanbuncha Y, Prachanukool T, Sawanyawisuth K

Therapeutics and Clinical Risk Management 2013, 9:377-381

Published Date: 8 October 2013

The effect of eradicating Helicobacter pylori on idiopathic central serous chorioretinopathy patients

Dang Y, Mu Y, Zhao M, Li L, Guo Y, Zhu Y

Therapeutics and Clinical Risk Management 2013, 9:355-360

Published Date: 2 September 2013

Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers

Del Tacca M, Pasqualetti G, Gori G, Pepe P, Di Paolo A, Lastella M, De Negri F, Blandizzi C

Therapeutics and Clinical Risk Management 2013, 9:303-311

Published Date: 24 July 2013

Evaluation of recombinant activated protein C for severe sepsis at a tertiary academic medical center

Anger KE, DeGrado JR, Greenwood BC, Cohen SA, Szumita PM

Therapeutics and Clinical Risk Management 2013, 9:277-284

Published Date: 5 June 2013

Case of femoral diaphyseal stress fracture after long-term risedronate administration diagnosed by iliac bone biopsy

Nagai T, Sakamoto K, Ishikawa K, Saito E, Kuroda T, Inagaki K

Therapeutics and Clinical Risk Management 2013, 9:191-195

Published Date: 30 April 2013

Vitamin D reduces falls and hip fractures in vascular Parkinsonism but not in Parkinson’s disease

Sato Y, Iwamoto J, Honda Y, Amano N

Therapeutics and Clinical Risk Management 2013, 9:171-176

Published Date: 22 April 2013

Tolerability of diclofenac sodium 1% gel with concomitant medications known to interact with diclofenac

Peniston JH, Gold MS, Wieman MS, Alwine LK

Therapeutics and Clinical Risk Management 2013, 9:153-159

Published Date: 16 April 2013

Clinical development of neridronate: potential for new applications

Gatti D, Rossini M, Viapiana O, Idolazzi L, Adami S

Therapeutics and Clinical Risk Management 2013, 9:139-147

Published Date: 3 April 2013

Gender, airborne chemical monitoring, and physical work environment are related to indoor air symptoms among nonindustrial workers in the Klang Valley, Malaysia

Syazwan AI, Hafizan J, Baharudin MR, Azman AZF, Izwyn Z, Zulfadhli I, Syahidatussyakirah K

Therapeutics and Clinical Risk Management 2013, 9:87-105

Published Date: 8 March 2013

Diagnosis and management of miliary tuberculosis: current state and future perspectives

Ray S, Talukdar A, Kundu S, Khanra D, Sonthalia N

Therapeutics and Clinical Risk Management 2013, 9:9-26

Published Date: 8 January 2013

Appropriateness of administration of nasogastric medication and preliminary intervention

Zhu LL, Xu LC, Wang HQ, Jin JF, Wang HF, Zhou Q

Therapeutics and Clinical Risk Management 2012, 8:393-401

Published Date: 20 November 2012

Consequences of neurologic lesions assessed by Barthel Index after Botox® injection may be underestimated

Dionyssiotis Y, Kiourtidis D, Karvouni A, Kaliontzoglou A, Kliafas I

Therapeutics and Clinical Risk Management 2012, 8:385-391

Published Date: 19 October 2012

Cost-effectiveness analysis of HIV treatment in the clinical practice of a public hospital in northern Italy

Rizzardini G, Bonfanti P, Carenzi L, Coen M, Orlando G, Di Matteo S, Colombo GL

Therapeutics and Clinical Risk Management 2012, 8:377-384

Published Date: 17 September 2012

Extreme intrafamilial variability of Saudi brothers with primary hyperoxaluria type 1

Alfadhel M, Alhasan KA, Alotaibi M, Al Fakeeh K

Therapeutics and Clinical Risk Management 2012, 8:373-376

Published Date: 28 August 2012

Efficacy of serum chitotriosidase activity in early treatment of patients with active tuberculosis and a negative sputum smear

Tasci C, Tapan S, Ozkaya S, Demirer E, Deniz O, Balkan A, Ozkan M, Inan I, Kurt I, Bilgic H

Therapeutics and Clinical Risk Management 2012, 8:369-372

Published Date: 27 August 2012

The first case of cutaneous infection with Mycobacterium parascrofulaceum

Zong WK, Zhang XD, Wang HS, Xu XL, Wang QL, Tian WW, Jin YL, Wu QX, Tang MY

Therapeutics and Clinical Risk Management 2012, 8:353-358

Published Date: 15 August 2012

Training in peroral endoscopic myotomy (POEM) for esophageal achalasia

Eleftheriadis N, Inoue H, Ikeda H, Onimaru M, Yoshida A, Hosoya T, Maselli R, Kudo S

Therapeutics and Clinical Risk Management 2012, 8:329-342

Published Date: 23 July 2012

Knowledge of adverse drug reaction reporting in first year postgraduate doctors in a medical college

Upadhyaya P, Seth V, Moghe VV, Sharma M, Ahmed M

Therapeutics and Clinical Risk Management 2012, 8:307-312

Published Date: 19 June 2012

Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab

Anastasilakis AD, Toulis KA, Polyzos SA, Anastasilakis CD, Makras P

Therapeutics and Clinical Risk Management 2012, 8:295-306

Published Date: 19 June 2012

Difficult airway and difficult intubation in postintubation tracheal stenosis: a case report and literature review

Zarogoulidis P, Kontakiotis T, Tsakiridis K, Karanikas M, Simoglou C, Porpodis K, Mitrakas A, Esebidis A, Konoglou M, Katsikogiannis N, Zervas V, Aggelopoulou C, Mikroulis D, Zarogoulidis K

Therapeutics and Clinical Risk Management 2012, 8:279-286

Published Date: 27 June 2012

Duloxetine in the management of chronic musculoskeletal pain

Smith HS, Smith EJ, Smith BR

Therapeutics and Clinical Risk Management 2012, 8:267-277

Published Date: 19 June 2012

Pharmacological management of binge eating disorder: current and emerging treatment options

McElroy SL, Guerdjikova AI, Mori N, O’Melia AM

Therapeutics and Clinical Risk Management 2012, 8:219-241

Published Date: 8 May 2012

Maximizing neuroprotection: where do we stand?

Kuffler DP

Therapeutics and Clinical Risk Management 2012, 8:185-194

Published Date: 10 April 2012

Interdisciplinary three-step strategy to treat aortic stenosis and coronary artery disease in a patient with end-stage chronic obstructive pulmonary disease

Michel S, Bigdeli AK, Beiras-Fernandez A, Schmitz C, Wolf M, Sodian R, Kaczmarek I

Therapeutics and Clinical Risk Management 2012, 8:181-183

Published Date: 11 April 2012

Measurement complexity of adherence to medication

Galato D, Schuelter-Trevisol F, Piovezan AP

Therapeutics and Clinical Risk Management 2012, 8:169-171

Published Date: 2 April 2012

Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype 1 infection: an indirect comparison meta-analysis

Cooper CL, Druyts E, Thorlund K, Nachega JB, El Khoury AC, O'Regan C, Mills EJ

Therapeutics and Clinical Risk Management 2012, 8:105-130

Published Date: 9 March 2012

Ruxolitinib for the treatment of myelofibrosis: its clinical potential

Ostojic A, Vrhovac R, Verstovsek S

Therapeutics and Clinical Risk Management 2012, 8:95-103

Published Date: 1 March 2012

NIHSS and acute complications after anterior and posterior circulation strokes

Boone M, Chillon JM, Garcia PY, Canaple S, Lamy C, Godefroy O, Bugnicourt JM

Therapeutics and Clinical Risk Management 2012, 8:87-93

Published Date: 27 February 2012

Daptomycin approved in Japan for the treatment of methicillin-resistant Staphylococcus aureus

Hagihara M, Umemura T, Mori T, Mikamo H

Therapeutics and Clinical Risk Management 2012, 8:79-86

Published Date: 17 February 2012

Coronary artery disease in Africa and the Middle East

Almahmeed W, Arnaout MS, Chettaoui R, Ibrahim M, Kurdi MI, Taher MA, Mancia G

Therapeutics and Clinical Risk Management 2012, 8:65-72

Published Date: 16 February 2012

Metabolic syndrome in a sample of the 6- to 16-year-old overweight or obese pediatric population: a comparison of two definitions

Saffari F, Jalilolghadr S, Esmailzadehha N, Azinfar P

Therapeutics and Clinical Risk Management 2012, 8:55-63

Published Date: 2 February 2012

New treatment options for lupus – a focus on belimumab

Chiche L, Jourde N, Thomas G, Bardin N, Bornet C, Darque A, Mancini J

Therapeutics and Clinical Risk Management 2012, 8:33-43

Published Date: 26 January 2012

Clinical utility of adjunctive retigabine in partial onset seizures in adults

Rejdak K, Luszczki JJ, Błaszczyk B, Chwedorowicz R, Czuczwar SJ

Therapeutics and Clinical Risk Management 2012, 8:7-14

Published Date: 20 January 2012

New antiangiogenics in non-small cell lung cancer treatment: Vargatef™ (BIBF 1120) and beyond

Gori B, Ricciardi S, Fulvi A, Intagliata S, Del Signore E, de Marinis F

Therapeutics and Clinical Risk Management 2011, 7:429-440

Published Date: 17 November 2011

Role of iron supplementation in promoting maternal and fetal outcome

Yekta Z, Pourali R, Mladkova N, Ghasemi-rad M , Boromand F, Hazrati Tappeh K

Therapeutics and Clinical Risk Management 2011, 7:421-428

Published Date: 31 October 2011

Critical appraisal of pralatrexate in the management of difficult-to-treat peripheral T cell lymphoma

Casanova M, Medina-Pérez A, Moreno-Beltran M, Mata-Vazquez M, Rueda A

Therapeutics and Clinical Risk Management 2011, 7:401-408

Published Date: 7 October 2011

Cancer patient-centered home care: a new model for health care in oncology

Tralongo P, Ferraù F, Borsellino N, Verderame F, Caruso M, Giuffrida D, Butera A, Gebbia V

Therapeutics and Clinical Risk Management 2011, 7:387-392

Published Date: 9 September 2011

The effect of a physician-targeted intervention on metoclopramide prescribing practice

Yang YX, Leonard CE, Freeman C, Hennessy S

Therapeutics and Clinical Risk Management 2011, 7:359-365

Published Date: 22 August 2011

Profile of ciclesonide for the maintenance treatment of asthma

Singas E, Karpel JP

Therapeutics and Clinical Risk Management 2011, 7:351-358

Published Date: 19 August 2011

Serum sodium disorders in patients with traumatic brain injury

Paiva WS, Bezerra DA, Amorim RL, Figueiredo EG, Tavares WM, De Andrade AF, Teixeira MJ

Therapeutics and Clinical Risk Management 2011, 7:345-349

Published Date: 11 August 2011

Effect of age on semen parameters in infertile men after varicocelectomy

Hassanzadeh-Nokashty K, Yavarikia P, Ghaffari A, Hazhir S, Hassanzadeh M

Therapeutics and Clinical Risk Management 2011, 7:333-336

Published Date: 9 August 2011

Treatment of acute otitis externa with ciprofloxacin otic 0.2% antibiotic ear solution

Mösges R, Nematian-Samani M, Eichel A

Therapeutics and Clinical Risk Management 2011, 7:325-326

Published Date: 27 July 2011

Prolonged-release melatonin for insomnia – an open-label long-term study of efficacy, safety, and withdrawal

Lemoine P, Garfinkel D, Laudon M, Nir T, Zisapel N

Therapeutics and Clinical Risk Management 2011, 7:301-311

Published Date: 26 July 2011

Seven years’ experience with etidronate in a woman with anorexia nervosa and vertebral fractures

Iwamoto J, Sato Y, Uzawa M, Takeda T, Matsumoto H

Therapeutics and Clinical Risk Management 2011, 7:275-281

Published Date: 5 July 2011

Conestat alfa for the treatment of angioedema attacks

Davis B, Bernstein JA

Therapeutics and Clinical Risk Management 2011, 7:265-273

Published Date: 1 July 2011

Clinical potential of lurasidone in the management of schizophrenia

Samalin L, Garnier M, Llorca PM

Therapeutics and Clinical Risk Management 2011, 7:239-250

Published Date: 27 June 2011

New form of administering chlorhexidine for treatment of denture-induced stomatitis

Ryalat S, Darwish R, Amin W

Therapeutics and Clinical Risk Management 2011, 7:219-225

Published Date: 14 June 2011

Quantifying the impact of nonadherence patterns on exposure to oral immunosuppressants

Maclean JR, Pfister M, Zhou Z, Roy A, Tuomari VA, Heifets M

Therapeutics and Clinical Risk Management 2011, 7:149-156

Published Date: 11 April 2011

Gynecomastia – evaluation and current treatment options

Murad MH, Johnson RE, Kermott CA

Therapeutics and Clinical Risk Management 2011, 7:145-148

Published Date: 28 March 2011

Atrial fibrillation and the use of oral bisphosphonates

Michael Pazianas, Cyrus Cooper, Yiting Wang, et al

Therapeutics and Clinical Risk Management 2011, 7:131-144

Published Date: 22 March 2011

Management of Huntington’s disease: role of tetrabenazine

Marina de Tommaso, Claudia Serpino, Vittorio Sciruicchio

Therapeutics and Clinical Risk Management 2011, 7:123-129

Published Date: 21 March 2011

Broadening the use of antiretroviral therapy: the case for feline leukemia virus

Willie M Greggs III, Christine L Clouser, Steven E Patterson, et al

Therapeutics and Clinical Risk Management 2011, 7:115-122

Published Date: 16 March 2011

Inferior vena cava filters in cancer patients: to filter or not to filter

Hikmat Abdel-Razeq, Asem Mansour, Yousef Ismael, et al

Therapeutics and Clinical Risk Management 2011, 7:99-102

Published Date: 10 March 2011

A causative link between periodontal disease and glomerulonephritis: a preliminary study

Mohammad Reza Ardalan, Kamyar Ghabili, Reza Pourabbas, et al

Therapeutics and Clinical Risk Management 2011, 7:93-98

Published Date: 8 March 2011

Pharmacological and clinical overview of cloperastine in treatment of cough

Maria Antonietta Catania, Salvatore Cuzzocrea

Therapeutics and Clinical Risk Management 2011, 7:83-92

Published Date: 7 March 2011

Enzyme replacement therapy for Fabry disease: some answers but more questions

Majid Alfadhel, Sandra Sirrs

Therapeutics and Clinical Risk Management 2011, 7:69-82

Published Date: 25 February 2011

A new Web-based medical tool for assessment and prevention of comprehensive cardiovascular risk

Daniele Franchi, Davide Cini, Giorgio Iervasi

Therapeutics and Clinical Risk Management 2011, 7:59-68

Published Date: 17 February 2011

Anorexia nervosa versus hyperinsulinism: therapeutic effects of neuropharmacological manipulation

Fuad Lechin, Bertha van der Dijs, Betty Pardey-Maldonado, et al

Therapeutics and Clinical Risk Management 2011, 7:53-58

Published Date: 17 February 2011

Genitourinary system trauma after 2003 Bam earthquake in Kerman, Iran

Mohammad Hasan Dehghani Firoozabadi, Mehdi Abedinzadeh, Mohammad Kazem Moslemi

Therapeutics and Clinical Risk Management 2011, 7:49-52

Published Date: 9 February 2011

Pirfenidone treatment of idiopathic pulmonary fibrosis

Ye Gan, Erica L Herzog, Richard H Gomer

Therapeutics and Clinical Risk Management 2011, 7:39-47

Published Date: 8 February 2011

Paroxysmal atrial fibrillation in cryptogenic stroke

Neha S Dangayach, Kevin Kane, Majaz Moonis

Therapeutics and Clinical Risk Management 2011, 7:33-37

Published Date: 28 January 2011

The lupus band test in systemic lupus erythematosus patients

Adam Reich, Katarzyna Marcinow, Rafal Bialynicki-Birula

Therapeutics and Clinical Risk Management 2011, 7:27-32

Published Date: 24 January 2011

Investigation of pulmonary infection pathogens in neurological intensive care unit

Fengying Quan, Guangwei Liu, Liang Wang, et al

Therapeutics and Clinical Risk Management 2011, 7:21-25

Published Date: 21 January 2011

Economic considerations of antifungal prophylaxis in patients undergoing surgical procedures

Maria Adriana Cataldo, Nicola Petrosillo

Therapeutics and Clinical Risk Management 2011, 7:13-20

Published Date: 13 January 2011

Role of rituximab in first-line treatment of chronic lymphocytic leukemia

Jeffrey Bryan, Gautam Borthakur

Therapeutics and Clinical Risk Management 2011, 7:1-11

Published Date: 22 December 2010

Reduced exercise capacity in persons with Down syndrome: cause, effect, and management

Goncalo V Mendonca, Fernando D Pereira1 Bo Fernhall

Therapeutics and Clinical Risk Management 2010, 6:601-610

Published Date: 8 December 2010

Does smoking really protect from recurrent aphthous stomatitis?

Faleh A Sawair

Therapeutics and Clinical Risk Management 2010, 6:573-577

Published Date: 22 November 2010

Comparative evaluation of prophylactic single-dose intravenous antibiotic with postoperative antibiotics in elective urologic surgery

Mohammad K Moslemi, Seyed M Moosavi Movahed, Akram Heidari, et al

Therapeutics and Clinical Risk Management 2010, 6:551-556

Published Date: 9 November 2010

New advances in the treatment of gout: review of pegloticase

Mattheus K Reinders, Tim L Th A Jansen

Therapeutics and Clinical Risk Management 2010, 6:543-550

Published Date: 27 October 2010

Portal vein thrombosis in a patient with HCV cirrhosis and combined hemophilia A and thrombophilia V Leiden

Nikos Eleftheriadis, Pantelis Makris

Therapeutics and Clinical Risk Management 2010, 6:539-541

Published Date: 26 October 2010

Emerging clinical role of ranolazine in the management of angina

David S Vadnais, Nanette K Wenger

Therapeutics and Clinical Risk Management 2010, 6:517-530

Published Date: 14 October 2010

Treatment of Cushing disease: overview and recent findings

Tatiana Mancini, Teresa Porcelli, Andrea Giustina

Therapeutics and Clinical Risk Management 2010, 6:505-516

Published Date: 12 October 2010

Role of teriparatide in treatment of glucocorticoid-induced osteoporosis

Arthur N Lau, Jonathan D Adachi

Therapeutics and Clinical Risk Management 2010, 6:497-503

Published Date: 12 October 2010

Pegylated liposomal doxorubicin in the management of ovarian cancer

Gabriella Ferrandina, Giacomo Corrado, Angelo Licameli, et al

Therapeutics and Clinical Risk Management 2010, 6:463-483

Published Date: 29 September 2010

An improved delivery system for bladder irrigation

Mohammad K Moslemi, Mojtaba Rajaei

Therapeutics and Clinical Risk Management 2010, 6:459-462

Published Date: 30 September 2010

Gastrointestinal stromal tumor (GIST) recurrence following surgery: review of the clinical utility of imatinib treatment

Isabelle Deshaies, Jovenel Cherenfant, Niraj J Gusani, et al

Therapeutics and Clinical Risk Management 2010, 6:453-458

Published Date: 22 September 2010

Intravenous lipid emulsion for treatment of local anesthetic toxicity

M Caroline Kosh, April D Miller, Jill E Michels

Therapeutics and Clinical Risk Management 2010, 6:449-451

Published Date: 24 September 2010

Microbial contamination of nonsterile pharmaceuticals in public hospital settings

Veronica Mugoyela, Kennedy D Mwambete

Therapeutics and Clinical Risk Management 2010, 6:443-448

Published Date: 10 September 2010

Role of tipranavir in treatment of patients with multidrug-resistant HIV

Joshua D Courter, Colleen J Teevan, Michael H Li, et al

Therapeutics and Clinical Risk Management 2010, 6:431-441

Published Date: 23 September 2010

Growth hormone deficiency and cerebral palsy

Jesús Devesa, Nerea Casteleiro, Cristina Rodicio, et al

Therapeutics and Clinical Risk Management 2010, 6:413-418

Published Date: 7 September 2010

Emerging oral treatments in multiple sclerosis – clinical utility of cladribine tablets

Claudio Gasperini, Serena Ruggieri, Carlo Pozzilli

Therapeutics and Clinical Risk Management 2010, 6:391-399

Published Date: 31 August 2010

Molecular mechanisms and treatment strategies for Dupuytren’s disease

David B O’Gorman, Linda Vi, Bing Siang Gan

Therapeutics and Clinical Risk Management 2010, 6:383-390

Published Date: 27 August 2010

Current and emerging treatments for the management of osteogenesis imperfecta

Elena Monti, Monica Mottes, Paolo Fraschini, et al

Therapeutics and Clinical Risk Management 2010, 6:367-381

Published Date: 24 August 2010

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis

Michael Pazianas, Cyrus Cooper, F Hal Ebetino, et al

Therapeutics and Clinical Risk Management 2010, 6:325-343

Published Date: 19 July 2010

Optimal therapy in Gaucher disease

Ozlem Goker-Alpan

Therapeutics and Clinical Risk Management 2010, 6:315-323

Published Date: 5 July 2010

Antibiotic prescribing practices by dentists: a review

Najla Saeed Dar-Odeh, Osama Abdalla Abu-Hammad, Mahmoud Khaled Al-Omiri, et al

Therapeutics and Clinical Risk Management 2010, 6:301-306

Published Date: 21 June 2010

Critical appraisal of a fixed combination of esomeprazole and low dose aspirin in risk reduction

Ravi Vachhani, Doumit Bouhaidar, Alvin Zfass, et al

Therapeutics and Clinical Risk Management 2010, 6:287-292

Published Date: 22 June 2010

Review of mifamurtide in the treatment of patients with osteosarcoma

Leo Kager, Ulrike Pötschger, Stefan Bielack

Therapeutics and Clinical Risk Management 2010, 6:279-286

Published Date: 15 June 2010

Investigation of clinical interaction between omeprazole and tacrolimus in CYP3A5 non-expressors, renal transplant recipients

Paraskevi F Katsakiori, Eirini P Papapetrou, Dimitrios S Goumenos, et al

Therapeutics and Clinical Risk Management 2010, 6:265-269

Published Date: 4 June 2010

Management of ANCA-associated vasculitis: Current trends and future prospects

Sally Hamour, Alan D Salama, Charles D Pusey

Therapeutics and Clinical Risk Management 2010, 6:253-264

Published Date: 3 June 2010

Maximum opening of the mouth by mouth prop during dental procedures increases the risk of upper airway constriction

Hiroshi Ito, Hiroyoshi Kawaai, Shinya Yamazaki, et al

Therapeutics and Clinical Risk Management 2010, 6:239-248

Published Date: 12 May 2010

Serum glutathione transferase does not respond to indole-3-carbinol: A pilot study

Daniel R McGrath, Hamid Frydoonfar, Joshua J Hunt, et al

Therapeutics and Clinical Risk Management 2010, 6:225-231

Published Date: 24 May 2010

Obesity is not associated with contrast nephropathy

Navin Jaipaul, Rendell Manalo, Seyed-Ali Sadjadi, et al

Therapeutics and Clinical Risk Management 2010, 6:213-217

Published Date: 5 May 2010

Equitable access to HCV care in HIV-HCV co-infection can be achieved despite barriers to health care provision

Curtis L Cooper, Celine Giordano, Dave Mackie, et al

Therapeutics and Clinical Risk Management 2010, 6:207-212

Published Date: 20 April 2010

Seven years’ experience with alendronate in postmenopausal Japanese women with osteoporosis

Jun Iwamoto, Yoshihiro Sato, Mitsuyoshi Uzawa, et al

Therapeutics and Clinical Risk Management 2010, 6:201-206

Published Date: 20 April 2010

Ropinirole in restless legs syndrome and periodic limb movement disorder

Daniel Erichsen, Raffaelle Ferri, David Gozal

Therapeutics and Clinical Risk Management 2010, 6:173-182

Published Date: 14 April 2010

Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis

Linda L Hushaw, Ray Sawaqed, Ghaleb Sweis, et al

Therapeutics and Clinical Risk Management 2010, 6:143-152

Published Date: 16 March 2010

Topical calcineurin inhibitors in systemic lupus erythematosus

Christos E Lampropoulos, David P D’Cruz

Therapeutics and Clinical Risk Management 2010, 6:95-101

Published Date: 13 April 2010

Abacavir/lamivudine combination in the treatment of HIV: a review

Geetha Sivasubramanian, Emmanuel Frempong-Manso, Rodger D MacArthur

Therapeutics and Clinical Risk Management 2010, 6:83-94

Published Date: 25 February 2010

Managing opioid-induced constipation in advanced illness: focus on methylnaltrexone bromide

Katri Elina Clemens, Eberhard Klaschik

Therapeutics and Clinical Risk Management 2010, 6:77-82

Published Date: 11 February 2010

Long-term maintenance of pediatric asthma: focus on budesonide/formoterol inhalation aerosol

Peter N Huynh, Lyne G Scott, Kenny YC Kwong

Therapeutics and Clinical Risk Management 2010, 6:65-75

Published Date: 8 February 2010

Profile of etravirine for the treatment of HIV infection

Alice Tseng, Rodger D MacArthur

Therapeutics and Clinical Risk Management 2010, 6:49-58

Published Date: 21 January 2010

Tenofovir-associated bone density loss

Iwen F Grigsby, Lan Pham, Louis M Mansky, et al

Therapeutics and Clinical Risk Management 2010, 6:41-47

Published Date: 24 December 2009

Current and emerging treatment options for Graves’ hyperthyroidism

Prakash Abraham, Shamasunder Acharya

Therapeutics and Clinical Risk Management 2010, 6:29-40

Published Date: 22 December 2009

Update on the efficacy, effectiveness and safety of artemether–lumefantrine combination therapy for treatment of uncomplicated malaria

Pauline Byakika-Kibwika, Mohammed Lamorde, Harriet Mayanja-Kizza, et al

Therapeutics and Clinical Risk Management 2010, 6:11-20

Published Date: 16 December 2009

In-hospital resuscitation: opioids and other factors influencing survival

Karamarie Fecho, Freeman Jackson, Frances Smith, et al

Therapeutics and Clinical Risk Management 2009, 5:961-968

Published Date: 8 December 2009

Monitored anesthesia care (MAC) sedation: clinical utility of fospropofol

Eric A Harris, David A Lubarsky, Keith A Candiotti

Therapeutics and Clinical Risk Management 2009, 5:949-959

Published Date: 8 December 2009

The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab

Richard Kelly, Stephen Richards, Peter Hillmen, et al

Therapeutics and Clinical Risk Management 2009, 5:911-921

Published Date: 18 November 2009

Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability

Andre R Brunoni, Renerio Fraguas Jr, Felipe Fregni

Therapeutics and Clinical Risk Management 2009, 5:897-910

Published Date: 17 November 2009

Update on the use of deferasirox in the management of iron overload

Ali Taher, Maria Domenica Cappellini

Therapeutics and Clinical Risk Management 2009, 5:857-868

Published Date: 30 October 2009

Pediatric psoriasis: an update

Nanette B Silverberg

Therapeutics and Clinical Risk Management 2009, 5:849-856

Published Date: 21 October 2009

The role of rifaximin in the treatment and chemoprophylaxis of travelers' diarrhea

Hoonmo L Koo, Herbert L DuPont, David B Huang

Therapeutics and Clinical Risk Management 2009, 5:841-848

Published Date: 21 October 2009

The role of urate and xanthine oxidase in vascular oxidative stress: future directions

Jacob George, Allan Struthers

Therapeutics and Clinical Risk Management 2009, 5:799-803

Published Date: 5 October 2009

Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer

Serena Ricciardi, Silverio Tomao, Filippo de Marinis

Therapeutics and Clinical Risk Management 2009, 5:781-787

Published Date: 25 September 2009

Dyslipidemia in Iranian overweight and obese children

Robabeh Ghergerehchi

Therapeutics and Clinical Risk Management 2009, 5:739-743

Published Date: 18 September 2009

Anticholinergic syndrome following an unintentional overdose of scopolamine

Carmela E Corallo, Ann Whitfield, Adeline Wu

Therapeutics and Clinical Risk Management 2009, 5:719-723

Published Date: 13 September 2009

Managing severe cancer pain: the role of transdermal buprenorphine: a systematic review

S Deandrea, O Corli, I Moschetti, et al

Therapeutics and Clinical Risk Management 2009, 5:707-718

Published Date: 4 September 2009

Role of everolimus in the treatment of renal cell carcinoma

Saby George, Ronald M Bukowski

Therapeutics and Clinical Risk Management 2009, 5:699-706

Published Date: 28 August 2009

Incretin-based therapies: new treatments for type 2 diabetes in the new millennium

Joan Khoo, Christopher K Rayner, Karen L Jones, et al

Therapeutics and Clinical Risk Management 2009, 5:683-698

Published Date: 20 August 2009

Managing pediatric hepatitis C: current and emerging treatment options

Wikrom Karnsakul, Mary Kay Alford, Kathleen B Schwarz

Therapeutics and Clinical Risk Management 2009, 5:651-660

Published Date: 13 August 2009

Pegylated liposomal doxorubicin in ovarian cancer

Robert Strother, Daniela Matei

Therapeutics and Clinical Risk Management 2009, 5:639-650

Published Date: 10 August 2009

Epileptic seizure after treatment with thiocolchicoside

Pedro Giavina-Bianchi, Mara Giavina-Bianchi, Luciana Kase Tanno, et al

Therapeutics and Clinical Risk Management 2009, 5:635-637

Published Date: 6 August 2009

Parenteral clevidipine for the acute control of blood pressure in the critically ill patient: a review

W Frank Peacock IV, Jorge E Angeles, Karina M Soto, et al

Therapeutics and Clinical Risk Management 2009, 5:627-634

Published Date: 4 August 2009

Current trends in the treatment of hepatic encephalopathy

Mohamad Rasm Al Sibae, Brendan M McGuire

Therapeutics and Clinical Risk Management 2009, 5:617-626

Published Date: 31 July 2009

Natalizumab in the treatment of multiple sclerosis

Brandon A Brown

Therapeutics and Clinical Risk Management 2009, 5:585-594

Published Date: 31 July 2009

Management strategies for pulmonary sarcoidosis

Robina Kate Coker

Therapeutics and Clinical Risk Management 2009, 5:575-584

Published Date: 23 July 2009

A comparative study of the prevalence of hyperkalemia with the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers

Seyed Ali Sadjadi, James I McMillan, Navin Jaipaul, Patricia Blakely, et al.

Therapeutics and Clinical Risk Management 2009, 5:547-552

Published Date: 10 July 2009

Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis

Devi Mukkai Krishnamurty, Atoosa Rabiee, Sanjay B Jagannath, Dana K Andersen

Therapeutics and Clinical Risk Management 2009, 5:507-520

Published Date: 2 July 2009

Does nonadherence to local recommendations for empirical antibiotic therapy on admission to the intensive care unit have an impact on in-hospital mortality?

Jean-Luc Baudel, Jacques Tankovic, Fabrice Carrat, Cécile Vigneau, et al.

Therapeutics and Clinical Risk Management 2009, 5:491-498

Published Date: 9 July 2009

Guidelines for the treatment of bacterial vaginosis: focus on tinidazole

Laura J Dickey, Michael D Nailor, Jack D Sobel

Therapeutics and Clinical Risk Management 2009, 5:485-489

Published Date: 23 June 2009

Substitution of anticonvulsant drugs

Bernhard J Steinhoff, Uwe Runge, Otto W Witte, Hermann Stefan, et al.

Therapeutics and Clinical Risk Management 2009, 5:449-457

Published Date: 22 June 2009

The benefits and risks of testosterone replacement therapy: a review

Nazem Bassil, Saad Alkaade, John E Morley

Therapeutics and Clinical Risk Management 2009, 5:427-448

Published Date: 11 June 2009

Treatment of recurrent epithelial ovarian cancer

Carmela Pisano, Giovanni S Bruni, Gaetano Facchini, Claudia Marchetti, et al.

Therapeutics and Clinical Risk Management 2009, 5:421-426

Published Date: 15 June 2009

Minimizing cardiac surgery risks in a Hepatitis C patient: Changing surgical strategy after evaluation by modern imaging technologies

Felix Kur, Andres Beiras-Fernandez, Martin Oberhoffer, Konstantin Nikolaou, et al.

Therapeutics and Clinical Risk Management 2009, 5:409-412

Published Date: 21 May 2009

Managing Behçet’s disease: An update on current and emerging treatment options

P LA van Daele, J H Kappen, P M van Hagen, J AM van Laar

Therapeutics and Clinical Risk Management 2009, 5:385-390

Published Date: 13 May 2009

Fatty liver in children

Mandana Rafeey, Fakhrossadat Mortazavi, Nafiseh Mogaddasi, Ghergherehchi Robabeh, et al.

Therapeutics and Clinical Risk Management 2009, 5:371-374

Published Date: 8 May 2009

Once-daily medications for the pharmacological management of ADHD in adults

Oleg v Tcheremissine, Lori M Lieving

Therapeutics and Clinical Risk Management 2009, 5:367-369

Published Date: 11 May 2009

Anthracycline extravasation injuries: management with dexrazoxane

Karin Jordan, Timo Behlendorf, Franziska Mueller, Hans-Joachim Schmoll

Therapeutics and Clinical Risk Management 2009, 5:361-366

Published Date: 8 May 2009

Current trends in the treatment of polycystic ovary syndrome with desire for children

Margalida E Sastre, Maria O Prat, Miguel Angel Checa, Ramon C Carreras

Therapeutics and Clinical Risk Management 2009, 5:353-360

Published Date: 8 May 2009

Associations of anemia persistency with medical expenditures in Medicare ESRD patients on dialysis

Jiannong Liu, Haifeng Guo, David Gilbertson, Robert Foley, et al.

Therapeutics and Clinical Risk Management 2009, 5:319-330

Published Date: 22 April 2009

Antimalarials and the fight against malaria in Brazil

Luiz MA Carmargo, Saulo de Oliveira, Sergio Basano, Célia RS Garcia

Therapeutics and Clinical Risk Management 2009, 5:311-317

Published Date: 22 April 2009

Management of glucocorticoids-induced osteoporosis: role of teriparatide

Silvia Migliaccio, Marina Brama, Nazzarena Malavolta

Therapeutics and Clinical Risk Management 2009, 5:305-310

Published Date: 17 April 2009

Cecal perforation with an ascending colon cancer caused by upper gastrointestinal endoscopy

Hiroyuki Miyatani, Yukio Yoshida, Hirokazu Kiyozaki

Therapeutics and Clinical Risk Management 2009, 5:301-303

Published Date: 3 April 2009

Dasatinib in chronic myeloid leukemia: a review

Dolly G Aguilera, Apostolia M Tsimberidou

Therapeutics and Clinical Risk Management 2009, 5:281-289

Published Date: 27 March 2009

Onset of action and seizure control in Lennox-Gaustaut syndrome: focus on rufinamide

Russell P Saneto, Gail D Anderson

Therapeutics and Clinical Risk Management 2009, 5:271-280

Published Date: 26 March 2009

Recombinant human epoetin beta in the treatment of chemotherapy-related anemia

Iain RJ Macpherson, Colin R Lindsay, Nicholas S Reed

Therapeutics and Clinical Risk Management 2009, 5:261-270

Published Date: 16 March 2009

Incidence and causes of neonatal hyperbilirubinemia in a center of Catania

Marco Sciuto, Gaetano Bertino, Mariangela Zocco, Ignazio Vecchio, et al.

Therapeutics and Clinical Risk Management 2009, 5:247-250

Published Date: 12 March 2009

Challenging issues in molecular-targeted therapy

Zoheir Ezziane

Therapeutics and Clinical Risk Management 2009, 5:239-245

Published Date: 3 March 2009

Role of oxaliplatin in the treatment of colorectal cancer

Pasquale Comella, Rossana Casaretti, Claudia Sandomenico, Antonio Avallone, Luca Franco

Therapeutics and Clinical Risk Management 2009, 5:229-238

Published Date: 4 March 2009

Biphosphonates-related osteonecrosis of the jaw: Clinical and physiopathological considerations

Alberto Borgioli, Christian Viviani, Marco Duvina, Leila Brancato, Giuseppe Spinelli, et al

Therapeutics and Clinical Risk Management 2009, 5:217-227

Published Date: 27 February 2009

Regimen complexity and medication nonadherence in elderly patients

Andrea Corsonello, Claudio Pedone, Fabrizia Lattanzio, Maria Lucchetti, Sabrina Garasto, et al.

Therapeutics and Clinical Risk Management 2009, 5:209-216

Published Date: 26 February 2009

Fludarabine in the treatment of chronic lymphocytic leukemia: a review

Francesca Ricci, Alessandra Tedeschi, Enrica Morra, Marco Montillo

Therapeutics and Clinical Risk Management 2009, 5:187-207

Published Date: 4 March 2009

Tenofovir and its potential in the treatment of hepatitis B virus

Laura Reynaud, Maria Aurora Carleo, Maria Talamo, Guglielmo Borgia

Therapeutics and Clinical Risk Management 2009, 5:177-185

Published Date: 2 February 2009

Mycophenolate mofetil: safety and efficacy in the prophylaxis of acute kidney transplantation rejection

Pranav Dalal, Monica Grafals, Darshika Chhabra, Lorenzo Gallon

Therapeutics and Clinical Risk Management 2009, 5:139-149

Published Date: 13 January 2009

Nd: YAG capsulotomy for posterior capsule opacification after combined clear corneal phacoemulsification and vitrectomy

Ilias Georgalas, Petros Petrou, George Kalantzis, Dimitrios Papaconstantinou, Chrysanthi Koutsandrea, Ioannis Ladas

Therapeutics and Clinical Risk Management 2009, 5:133-137

Published Date: 11 January 2009

Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses

Hideki Hasegawa, Takeshi Ichinohe, Akira Ainai, Shin-ichi Tamura, Takeshi Kurata

Therapeutics and Clinical Risk Management 2009, 5:125-132

Published Date: 9 March 2009

Role of atazanavir in the treatment of HIV infection

Pablo Rivas, Judit Morello, Carolina Garrido, Sonia Rodríguez-Nóvoa, Vincent Soriano

Therapeutics and Clinical Risk Management 2009, 5:99-116

Published Date: 17 December 2008

A review of the use of exemestane in early breast cancer

Andrew Robinson

Therapeutics and Clinical Risk Management 2009, 5:91-98

Published Date: 11 December 2008

Angioid streaks, clinical course, complications, and current therapeutic management

Ilias Georgalas, Dimitris Papaconstantinou, Chrysanthi Koutsandrea, George Kalantzis, Dimitris Karagiannis, et al

Therapeutics and Clinical Risk Management 2009, 5:81-89

Published Date: 9 December 2008

Life-threatening hemorrhage following subcutaneous heparin therapy

Jana Hudcova, Daniel Talmor

Therapeutics and Clinical Risk Management 2009, 5:51-54

Published Date: 2 December 2008

Topical retapamulin in the management of infected traumatic skin lesions

Ribhi Shawar, Nicole Scangarella-Oman, MaryBeth Dalessandro, John Breton, Monique Twynholm, et al

Therapeutics and Clinical Risk Management 2009, 5:41-49

Published Date: 4 December 2008

Management of postoperative nausea and vomiting: focus on palonosetron

Neil A Muchatuta, Michael J Paech

Therapeutics and Clinical Risk Management 2009, 5:21-34

Published Date: 30 November 2008

Severe hypotony and filtering bleb leak after intravitreal injection of ranibizumab

Ilias Georgalas, Dimitris Papaconstantinou, Ioannis Tservakis, Chrysanthi Koutsandrea, Ioannis Ladas

Therapeutics and Clinical Risk Management 2009, 5:17-19

Published Date: 27 November 2008

Regular use of traditional analgesics predicts major coronary events: A cohort study

Mikko Haara, Markku Heliövaara, Jari PA Arokoski, Paul Knekt, Pirjo Manninen, et al

Therapeutics and Clinical Risk Management 2009, 5:9-15

Published Date: 2 December 2008

Erratum

Rapidis A, Sarlis N, Lefebvre J-L, et al

Therapeutics and Clinical Risk Management 2008, 4:1381-1381

Published Date: 5 December 2008

A thyrotoxicosis outbreak due to dietary pills in Paris

Vincent Ioos, Vincent Das, Eric Maury, Jean-Luc Baudel, Jérôme Guéchot, et al

Therapeutics and Clinical Risk Management 2008, 4:1375-1379

Published Date: 5 December 2008

Safe and tolerable one-hour pamidronate infusion for multiple myeloma patients

Dimitrios Chantzichristos, Andréasson Björn, Johansson Peter

Therapeutics and Clinical Risk Management 2008, 4:1371-1374

Published Date: 5 December 2008

Takotsubo cardiomyopathy in two men receiving bevacizumab for metastatic cancer

Thérèse H Franco, Ahmed Khan, Vishal Joshi, Beje Thomas

Therapeutics and Clinical Risk Management 2008, 4:1367-1370

Published Date: 5 December 2008

Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapy

Tamana Walia, J Fernando Quevedo, Timothy J Hobday, Gary Croghan, Aminah Jatoi

Therapeutics and Clinical Risk Management 2008, 4:1363-1366

Published Date: 5 December 2008

Evaluation of cardiotoxicity five years after 2D planned, non-simulated, radiation therapy for left breast cancer

Kyriaki Pistevou-Gompaki, Apostolos Hatzitolios, Nikos Eleftheriadis, Evaggelos Boultoukas, George Ntaios, et al

Therapeutics and Clinical Risk Management 2008, 4:1359-1362

Published Date: 5 December 2008

Effects of treatment with antimicrobial agents on the human colonic microflora

Fatemeh Rafii, John B Sutherland, Carl E Cerniglia

Therapeutics and Clinical Risk Management 2008, 4:1343-1357

Published Date: 5 December 2008

Newer treatments for fibromyalgia syndrome

Richard E Harris, Daniel J Clauw

Therapeutics and Clinical Risk Management 2008, 4:1331-1342

Published Date: 5 December 2008

Tadalafil in the treatment of erectile dysfunction

Robert M Coward, Culley C Carson

Therapeutics and Clinical Risk Management 2008, 4:1315-1329

Published Date: 5 December 2008

Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis

José Luis Callejas-Rubio, Lourdes López-Pérez, Norberto Ortego-Centeno

Therapeutics and Clinical Risk Management 2008, 4:1305-1313

Published Date: 5 December 2008

Exemestane in early breast cancer: a review

Michael Untch, Christian Jackisch

Therapeutics and Clinical Risk Management 2008, 4:1295-1304

Published Date: 5 December 2008

Vinflunine in the treatment of bladder cancer

Mark Bachner, Maria De Santis

Therapeutics and Clinical Risk Management 2008, 4:1243-1253

Published Date: 5 December 2008

Bazedoxifene for the prevention of postmenopausal osteoporosis

Luigi Gennari, Daniela Merlotti, Vincenzo De Paola, Giuseppe Martini, Ranuccio Nuti

Therapeutics and Clinical Risk Management 2008, 4:1229-1242

Published Date: 5 December 2008

Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab

Daanish Hoda, George R Simon, Christopher R Garrett

Therapeutics and Clinical Risk Management 2008, 4:1221-1227

Published Date: 5 December 2008

Febuxostat in the management of hyperuricemia and chronic gout: a review

Miao Hu, Brian Tomlinson

Therapeutics and Clinical Risk Management 2008, 4:1209-1220

Published Date: 5 December 2008

Mometasone furoate in the management of asthma: a review

Ricardo A Tan, Jonathan Corren

Therapeutics and Clinical Risk Management 2008, 4:1201-1208

Published Date: 5 December 2008

Impact of PPIs on patient focused symptomatology in GERD

ABR Thomson

Therapeutics and Clinical Risk Management 2008, 4:1185-1200

Published Date: 5 December 2008

Treatment of severe psoriasis with infliximab

JA Leman, AD Burden

Therapeutics and Clinical Risk Management 2008, 4:1165-1175

Published Date: 5 December 2008

Gemcitabine and taxanes in metastatic breast cancer: a systematic review

Vinay Gudena, Alberto J Montero, Stefan Glück

Therapeutics and Clinical Risk Management 2008, 4:1157-1164

Published Date: 5 December 2008

Tolvaptan and its potential in the treatment of hyponatremia

Megan B Dixon, Y Howard Lien

Therapeutics and Clinical Risk Management 2008, 4:1149-1155

Published Date: 5 December 2008

Brain abscess as a manifestation of spinal dermal sinus

Parisa Emami-Naeini, Ali Mahdavi, Hamed Ahmadi, Nima Baradaran, Farideh Nejat

Therapeutics and Clinical Risk Management 2008, 4:1143-1147

Published Date: 10 October 2008

Methotrexate-induced cutaneous ulceration in patients with erythrodermic mycosis fungoides

Debra L Breneman, Timothy J Storer, John C Breneman, Diya F Mutasim

Therapeutics and Clinical Risk Management 2008, 4:1135-1141

Published Date: 10 October 2008

A pilot feasibility study of daily rTMS to modify corticospinal excitability during lower limb immobilization

Raffaella Ricci, Dave Ramsey, Kevin Johnson, Jeffrey J Borckardt, Matthew Vallejo, et al

Therapeutics and Clinical Risk Management 2008, 4:1127-1134

Published Date: 10 October 2008

Analysis of clinical records of dental patients attending Jordan University Hospital: Documentation of drug prescriptions and local anesthetic injections

Najla Dar-Odeh, Soukaina Ryalat, Mohammad Shayyab, Osama Abu-Hammad

Therapeutics and Clinical Risk Management 2008, 4:1111-1117

Published Date: 10 October 2008

Assessment of acceptability and ease of use of atovaquone/proguanil medication in subjects undergoing malaria prophylaxis

V Nicosia, Giorgio Colombo, M Consentino, S Di Matteo, F Mika, et al

Therapeutics and Clinical Risk Management 2008, 4:1105-1110

Published Date: 10 October 2008

Effects of extracted soy isoflavones alone on blood total and LDL cholesterol: Meta-analysis of randomized controlled trials

Kyoko Taku, Keizo Umegaki, Yoshiko Ishimi, Shaw Watanabe

Therapeutics and Clinical Risk Management 2008, 4:1097-1103

Published Date: 10 October 2008

Bowen’s disease – a review of newer treatment options

Thorsten Neubert, Percy Lehmann

Therapeutics and Clinical Risk Management 2008, 4:1085-1095

Published Date: 10 October 2008

Weekly docetaxel in the treatment of metastatic breast cancer

Laura Palmeri, Marina Vaglica, Sergio Palmeri

Therapeutics and Clinical Risk Management 2008, 4:1047-1059

Published Date: 10 October 2008

Lopinavir/ritonavir in the treatment of HIV-1 infection: a review

Ashish Chandwani, Jonathan Shuter

Therapeutics and Clinical Risk Management 2008, 4:1023-1033

Published Date: 10 October 2008

Review of docetaxel in the treatment of gastric cancer

Eric D Tetzlaff, Jonathan D Cheng, Jaffer A Ajani

Therapeutics and Clinical Risk Management 2008, 4:999-1007

Published Date: 10 October 2008

Risk management profile of etoricoxib: an example of personalized medicine

Paola Patrignani, Stefania Tacconelli, Marta L Capone

Therapeutics and Clinical Risk Management 2008, 4:983-997

Published Date: 10 October 2008

Treatment of hereditary angioedema with plasma-derived C1 inhibitor

Michael J Prematta, Tracy Prematta, Timothy J Craig

Therapeutics and Clinical Risk Management 2008, 4:975-982

Published Date: 10 October 2008

Management of postoperative ileus: focus on alvimopan

Eric L Marderstein, Conor P Delaney

Therapeutics and Clinical Risk Management 2008, 4:965-973

Published Date: 10 October 2008

New advances in the treatment of Clostridium difficile infection (CDI)

Dennis D Hedge, Joe D Strain, Jodi R Heins, Debra K Farver

Therapeutics and Clinical Risk Management 2008, 4:949-964

Published Date: 10 October 2008

Multi-targeted approach in the treatment of thyroid cancer

Scott N Pinchot, Rebecca S Sippel, Herbert Chen

Therapeutics and Clinical Risk Management 2008, 4:935-947

Published Date: 10 October 2008

Treatment of Crohn’s disease with colony-stimulating factors: An overview

Luisa Guidi, Giammarco Mocci, Manuela Marzo, Sergio Rutella

Therapeutics and Clinical Risk Management 2008, 4:927-934

Published Date: 10 October 2008

Spontaneous bacterial peritonitis: How to deal with this life-threatening cirrhosis complication?

Tarsila CR Ribeiro, Julio MF Chebli, Mario Kondo, Pedro Duarte Gaburri, Liliana Andrade Chebli, Ana Cristina Amaral Feldner

Therapeutics and Clinical Risk Management 2008, 4:919-925

Published Date: 10 October 2008

Postoperative ileus: strategies for reduction

James Lubawski, Theodore Saclarides

Therapeutics and Clinical Risk Management 2008, 4:913-917

Published Date: 10 October 2008

Evaluation of extended and continuous use oral contraceptives

Kristen Page Wright, Julia V Johnson

Therapeutics and Clinical Risk Management 2008, 4:905-911

Published Date: 10 October 2008

Pharmacological management of acute bronchiolitis

Melvin Wright, Charles J Mullett, Giovanni Piedimonte

Therapeutics and Clinical Risk Management 2008, 4:895-903

Published Date: 10 October 2008

Phosphate binding therapy in dialysis patients: focus on lanthanum carbonate

Ismail A Mohammed, Alastair J Hutchison

Therapeutics and Clinical Risk Management 2008, 4:887-893

Published Date: 10 October 2008

Docetaxel in the treatment of squamous cell carcinoma of the head and neck

Alexander Rapidis, Nicholas Sarlis, Jean-Louis Lefebvre, Merrill Kies

Therapeutics and Clinical Risk Management 2008, 4:865-886

Published Date: 10 October 2008

Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations

Gabriele Nicolini, Nicola Scichilone, Andrea Bizzi, Alberto Papi, Leonardo M Fabbri

Therapeutics and Clinical Risk Management 2008, 4:855-864

Published Date: 10 October 2008

Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis

Jessina C McGregor, George P Allen, David T Bearden

Therapeutics and Clinical Risk Management 2008, 4:843-853

Published Date: 10 October 2008

A 41-year-old man with polyarthritis and severe autonomic neuropathy

Matthew E Bourcier, Aaron I Vinik

Therapeutics and Clinical Risk Management 2008, 4:837-842

Published Date: 8 August 2008

Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis

Vincenzo Savica, Domenico Santoro, Paolo Monardo, Agostino Mallamace, Guido Bellinghieri

Therapeutics and Clinical Risk Management 2008, 4:821-826

Published Date: 8 August 2008

Interleukin-6 inhibitors in the treatment of rheumatoid arthritis

Stephanie Hennigan, Arthur Kavanaugh

Therapeutics and Clinical Risk Management 2008, 4:767-775

Published Date: 8 August 2008

Combating HIV resistance – focus on darunavir

Cécile L Tremblay

Therapeutics and Clinical Risk Management 2008, 4:759-765

Published Date: 8 August 2008

Posaconazole in the management of refractory invasive fungal infections

Stefan Langner, Philipp B Staber, Peter Neumeister

Therapeutics and Clinical Risk Management 2008, 4:747-757

Published Date: 8 August 2008

Fospropofol disodium injection for the sedation of patients undergoing colonoscopy

Benjamin E Levitzky, John J Vargo

Therapeutics and Clinical Risk Management 2008, 4:733-738

Published Date: 8 August 2008

Availability of a remote online hemodynamic monitoring system during treatment in a private dental office for medically high-risk patients

Shinya Yamazaki, Hiroyoshi Kawaai, Shigeo Sasaki, Kazuhiro Shimamura, Hiroshi Segawa, Takahiro Saito

Therapeutics and Clinical Risk Management 2008, 4:721-726

Published Date: 8 August 2008

Silent myocardial infarction in women with type II diabetes mellitus and microalbuminuria

Elmir Omerovic, Gerhard Brohall, Markus Müller, Truls Råmunddal, Göran Matejka, et al

Therapeutics and Clinical Risk Management 2008, 4:705-711

Published Date: 8 August 2008

Early ischemic CT changes before thrombolysis: The influence of age and diabetes mellitus

Lars Thomassen, Ulrike Waje-Andreassen, Halvor Naess

Therapeutics and Clinical Risk Management 2008, 4:699-703

Published Date: 8 August 2008

Risk stratification for arrhythmic death in an emergency department cohort: a new method of nonlinear PD2i analysis of the ECG

James E Skinner, Michael Meyer, William C Dalsey, Brian A Nester, George Ramalanjaona, et al

Therapeutics and Clinical Risk Management 2008, 4:689-697

Published Date: 8 August 2008

Postoperative mortality after inpatient surgery: Incidence and risk factors

Karamarie Fecho, Anne T Lunney, Philip G Boysen, Peter Rock, Edward A Norfleet

Therapeutics and Clinical Risk Management 2008, 4:681-688

Published Date: 8 August 2008

A systematic approach of tracking and reporting medication errors at a tertiary care university hospital, Karachi, Pakistan

Khurshid Khowaja, Rozmin Nizar, Rashida J Merchant, Jacqueline Dias, Irma Bustamante-Gavino, Amina Malik

Therapeutics and Clinical Risk Management 2008, 4:673-679

Published Date: 8 August 2008

Pain treatment with high-dose, controlled-release oxycodone: an Italian perspective

Fabio Ferrarese, Gioia Becchimanzi, Massimo Bernardo, Maria Anna Conte, Angela Gioia, et al

Therapeutics and Clinical Risk Management 2008, 4:665-671

Published Date: 8 August 2008

Concurrent Chagas’ disease and borderline disseminated cutaneous leishmaniasis: The role of amiodarone as an antitrypanosomatidae drug

Alberto E Paniz-Mondolfi, Alexandra M Pérez-Álvarez, Oscar Reyes-Jaimes, Gustavo Socorro, Olga Zerpa, et al

Therapeutics and Clinical Risk Management 2008, 4:659-663

Published Date: 6 June 2008

An “acquired” hemoglobin J variant in a sickle cell disease patient

Nawwar Swedan, Kathleen Nicol, Phylis Moder, Samir Kahwash

Therapeutics and Clinical Risk Management 2008, 4:649-652

Published Date: 6 June 2008

Valproate-associated reversible encephalopathy in a 3-year-old girl with Pallister-Killian syndrome

Thorsten Gerstner, Nellie Bell, Stephan A Koenig

Therapeutics and Clinical Risk Management 2008, 4:645-647

Published Date: 6 June 2008

Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time

Tam Ly, Jyoti Gulia, Vasilios Pyrgos, Masashi Waga, Shmuel Shoham

Therapeutics and Clinical Risk Management 2008, 4:637-640

Published Date: 6 June 2008

Performance of the OptiMAL® dipstick in the diagnosis of malaria infection in pregnancy

Harry Tagbor, Jane Bruce, Edmund Browne, Brian Greenwood, Daniel Chandramohan

Therapeutics and Clinical Risk Management 2008, 4:631-636

Published Date: 6 June 2008

Multiple sclerosis presented as clinically isolated syndrome: the need for early diagnosis and treatment

Sigliti-Henrietta Pelidou, Sotirios Giannopoulos, Sotiria Tzavidi, Georgios Lagos, Athanassios P Kyritsis

Therapeutics and Clinical Risk Management 2008, 4:627-630

Published Date: 6 June 2008

Treatment strategies in mucous membrane pemphigoid

Ann G Neff, Matthew Turner, Diya F Mutasim

Therapeutics and Clinical Risk Management 2008, 4:617-626

Published Date: 6 June 2008

The therapeutic effects of Rho-ROCK inhibitors on CNS disorders

Takekazu Kubo, Atsushi Yamaguchi, Nobuyoshi Iwata, Toshihide Yamashita

Therapeutics and Clinical Risk Management 2008, 4:605-615

Published Date: 6 June 2008

Antiviral treatment in patients with hepatitis C virus-related cirrhosis awaiting liver transplantation

Pierluigi Toniutto, Carlo Fabris, Davide Bitetto, Ezio Fornasiere, Elisa Fumolo, et al

Therapeutics and Clinical Risk Management 2008, 4:599-603

Published Date: 6 June 2008

AAS, growth hormone, and insulin abuse: psychological and neuroendocrine effects

Michael R Graham, Peter Evans, Bruce Davies, Julien S Baker

Therapeutics and Clinical Risk Management 2008, 4:587-597

Published Date: 6 June 2008

Atripla™ – HIV therapy in one pill

Boris Julg, Johannes R Bogner

Therapeutics and Clinical Risk Management 2008, 4:573-577

Published Date: 6 June 2008

Editorial  ||FREE PAPER||

Garry M Walsh

Therapeutics and Clinical Risk Management 2008, 4:0-0

Published Date: 6 June 2008

Towards a new standard of perioperative fluid management

Conor J Shields

Therapeutics and Clinical Risk Management 2008, 4:569-571

Published Date: 11 April 2008

Moderate and severe plaque psoriasis: cost-of-illness study in Italy

GL Colombo, GF Altomare, K Peris, P Martini, G Quarta

Therapeutics and Clinical Risk Management 2008, 4:559-568

Published Date: 11 April 2008

Managing anemia in lymphoma and multiple myeloma

Gunnar Birgegård

Therapeutics and Clinical Risk Management 2008, 4:527-539

Published Date: 11 April 2008

Leuprorelin depot injection: patient considerations in the management of prostatic cancer

Zinelabidine Abouelfadel, E David Crawford

Therapeutics and Clinical Risk Management 2008, 4:513-526

Published Date: 11 April 2008

A review of nasal polyposis

Jonathan Ray Newton, Kim Wong Ah-See

Therapeutics and Clinical Risk Management 2008, 4:507-512

Published Date: 11 April 2008

Raltegravir: first in class HIV integrase inhibitor

Zelalem Temesgen, Dawd S Siraj

Therapeutics and Clinical Risk Management 2008, 4:493-500

Published Date: 11 April 2008

New approaches in the treatment of HIV/AIDS – focus on maraviroc and other CCR5 antagonists

Hans P Schlecht, Sarah Schellhorn, Bruce J Dezube, Jeffrey M Jacobson

Therapeutics and Clinical Risk Management 2008, 4:473-485

Published Date: 11 April 2008

Fluticasone furoate nasal spray in the treatment of allergic rhinitis

Pedro Giavina-Bianchi, Rosana Agondi, Rafael Stelmach, Alberto Cukier, Jorge Kalil

Therapeutics and Clinical Risk Management 2008, 4:465-472

Published Date: 11 April 2008

Alemtuzumab in the up-front setting

Matthew Kaufman, Kanti R Rai

Therapeutics and Clinical Risk Management 2008, 4:459-464

Published Date: 11 April 2008

Use of ibandronate in the prevention of skeletal events in metastatic breast cancer

Bianca Devitt, Sue-Anne McLachlan

Therapeutics and Clinical Risk Management 2008, 4:453-458

Published Date: 11 April 2008

Enfuvirtide antiretroviral therapy in HIV-1 infection

Christina MR Kitchen, Miriam Nuño, Scott G Kitchen, Paul Krogstad

Therapeutics and Clinical Risk Management 2008, 4:433-439

Published Date: 11 April 2008

Docetaxel for the post-surgery treatment of patients with node-positive breast cancer

Shubham Pant, Meena P Chilukuri, Bhuvaneswari Ramaswamy

Therapeutics and Clinical Risk Management 2008, 4:419-424

Published Date: 11 April 2008

Single-day treatment for orolabial and genital herpes: a brief review of pathogenesis and pharmacology

Sapna Modi, Livia Van, Aron Gewirtzman, Natalia Mendoza, Brenda Bartlett, et al

Therapeutics and Clinical Risk Management 2008, 4:409-417

Published Date: 11 April 2008

Developments in the management of autosomal dominant polycystic kidney disease

Amirali Masoumi, Berenice Reed-Gitomer, Catherine Kelleher, Mir Reza Bekheirnia, Robert W Schrier

Therapeutics and Clinical Risk Management 2008, 4:393-407

Published Date: 11 April 2008

Update on local anesthetics: focus on levobupivacaine

Crina L Burlacu, Donal J Buggy

Therapeutics and Clinical Risk Management 2008, 4:381-392

Published Date: 11 April 2008

New approaches to managing asthma: a US perspective

William E Berger

Therapeutics and Clinical Risk Management 2008, 4:363-379

Published Date: 11 April 2008

New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide

F Braido, C Lagasio, IMG Piroddi, I Baiardini, GW Canonica

Therapeutics and Clinical Risk Management 2008, 4:353-361

Published Date: 11 April 2008

Treating psoriasis with adalimumab

Eihab A Alwawi, Stephanie L Mehlis, Kenneth B Gordon

Therapeutics and Clinical Risk Management 2008, 4:345-351

Published Date: 11 April 2008

Treating refractory leukemias in childhood, role of clofarabine

Theresa M Harned, Paul S Gaynon

Therapeutics and Clinical Risk Management 2008, 4:327-336

Published Date: 11 April 2008

Conivaptan: a step forward in the treatment of hyponatremia?

Su Su Hline, Phuong-Truc T Pham, Phuong-Thu T Pham, May H Aung, Phuong-Mai T Pham, Phuong-Chi T Pham

Therapeutics and Clinical Risk Management 2008, 4:315-326

Published Date: 11 April 2008

“One pill, once daily”: what clinicians need to know about Atripla™

Patrick G Clay, Tracey AH Taylor, Alan G Glaros, MaryPeace McRae, Charlott Williams, et al

Therapeutics and Clinical Risk Management 2008, 4:291-302

Published Date: 11 April 2008

Treating oligohydramnios with extract of Salvia miltiorrhiza: A randomized control trial

Hong-nü Chu, Mei-juan Shen

Therapeutics and Clinical Risk Management 2008, 4:287-290

Published Date: 8 February 2008

Factors affecting therapeutic compliance: A review from the patient’s perspective

Jing Jin, Grant Edward Sklar, Vernon Min Sen Oh, Shu Chuen Li

Therapeutics and Clinical Risk Management 2008, 4:269-286

Published Date: 8 February 2008

Zoledronic acid in the management of metastatic bone disease

Thomas J Polascik, Vladimir Mouraviev

Therapeutics and Clinical Risk Management 2008, 4:261-268

Published Date: 8 February 2008

Cannabinoids in the management of difficult to treat pain

Ethan B Russo

Therapeutics and Clinical Risk Management 2008, 4:245-259

Published Date: 8 February 2008

A review of telavancin in the treatment of complicated skin and skin structure infections (cSSSI)

Lala M Dunbar, Derek M Tang, Robert M Manausa

Therapeutics and Clinical Risk Management 2008, 4:235-244

Published Date: 8 February 2008

Management of laryngopharyngeal reflux with proton pump inhibitors

Christina Reimer, Peter Bytzer

Therapeutics and Clinical Risk Management 2008, 4:225-233

Published Date: 8 February 2008

Therapeutical approach to plasma homocysteine and cardiovascular risk reduction

Marcello Ciaccio, Giulia Bivona, Chiara Bellia

Therapeutics and Clinical Risk Management 2008, 4:219-224

Published Date: 8 February 2008

A review of topotecan in combination chemotherapy for advanced cervical cancer

Minoo Robati, David Holtz, Charles J Dunton

Therapeutics and Clinical Risk Management 2008, 4:213-218

Published Date: 8 February 2008

Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec®, Gleevec™)

Martin Henkes, Heiko van der Kuip, Walter E Aulitzky

Therapeutics and Clinical Risk Management 2008, 4:163-187

Published Date: 8 February 2008

Treatment of gastrointestinal stromal tumor: focus on imatinib mesylate

Omar S Din, Penella J Woll

Therapeutics and Clinical Risk Management 2008, 4:149-162

Published Date: 8 February 2008

Calcipotriol/betamethasone dipropionate in the treatment of psoriasis vulgaris

Efstratios Vakirlis, Athanasios Kastanis, Demetrios Ioannides

Therapeutics and Clinical Risk Management 2008, 4:141-148

Published Date: 8 February 2008

A review of lenalidomide in combination with dexamethasone for the treatment of multiple myeloma

Teru Hideshima, Noopur Raje, Paul G Richardson, Kenneth C Anderson

Therapeutics and Clinical Risk Management 2008, 4:129-136

Published Date: 8 February 2008

A review of solifenacin in the treatment of urinary incontinence

Ramandeep Basra, Con Kelleher

Therapeutics and Clinical Risk Management 2008, 4:117-128

Published Date: 8 February 2008

Trabectedin and its potential in the treatment of soft tissue sarcoma

Philippe A Cassier, Armelle Dufresne, Jean-Yves Blay, Jérôme Fayette

Therapeutics and Clinical Risk Management 2008, 4:109-116

Published Date: 8 February 2008

A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting

Mark A Ware, Paul Daeninck, Vincent Maida

Therapeutics and Clinical Risk Management 2008, 4:99-107

Published Date: 8 February 2008

Advances in the use of topical imiquimod to treat dermatologic disorders

Francesco Lacarrubba, Maria Rita Nasca, Giuseppe Micali

Therapeutics and Clinical Risk Management 2008, 4:87-97

Published Date: 8 February 2008

Anidulafungin in the treatment of invasive fungal infections

Kathryn Sabol, Tawanda Gumbo

Therapeutics and Clinical Risk Management 2008, 4:71-78

Published Date: 8 February 2008

Why does the world need another rotavirus vaccine?

Richard L Ward, Monica M McNeal, A Duncan Steele

Therapeutics and Clinical Risk Management 2008, 4:49-63

Published Date: 8 February 2008

Serotonin receptor modulators in the treatment of irritable bowel syndrome

Mohammad Fayyaz, Jeffrey M Lackner

Therapeutics and Clinical Risk Management 2008, 4:41-48

Published Date: 8 February 2008

Dalbavancin in the treatment of complicated skin and soft-tissue infections: a review

Jason W Bennett, James S Lewis II, Michael W Ellis

Therapeutics and Clinical Risk Management 2008, 4:31-40

Published Date: 8 February 2008

Tamsulosin oral controlled absorption system (OCAS) in the treatment of benign prostatic hypertrophy

Mischel G Neill, Rohan Shahani, Alexandre R Zlotta

Therapeutics and Clinical Risk Management 2008, 4:11-18

Published Date: 8 February 2008

Review of photodynamic therapy in actinic keratosis and basal cell carcinoma

Marica B Ericson, Ann-Marie Wennberg, Olle Larkö

Therapeutics and Clinical Risk Management 2008, 4:1-9

Published Date: 8 February 2008